Human adult olfactory neural progenitors rescue	1
rodent rubrospinal neurons	60
functional recovery Ming Xiaoa	99
b	131
Kathleen M. Kluebera	134
Chengliang Lua	156
Zhanfang Guoa	172
Charles T. Marshalla	187
Heming Wanga	209
b	222
Fred J. Roisena	225
T Abstract Previously	241
T Abstract	241
our lab	265
the isolation	282
patient-specific neurosphere-forming progenitor lines	299
human adult olfactory epithelium	358
cadavers as well as patients	396
nasal sinus surgery	436
RT-PCR and ELISA	457
the neurosphere-forming cells -LRB- NSFCs -RRB-	492
the neurosphere-forming cells	492
NSFCs	523
BDNF	539
rubrospinal tract -LRB- RST -RRB- neurons	551
rubrospinal tract	551
RST	570
exogenous BNDF	613
it	629
the NSFCs	657
viable following engraftment	676
traumatized spinal cord	710
they	735
RS neurons	764
retrograde cell atrophy	780
functional recovery	816
One week	837
a partial cervical hemisection	852
GFP-labeled NSFCs suspended in MatrigelR matrix or MatrigelR matrix	884
GFP-labeled NSFCs	884
MatrigelR matrix or MatrigelR matrix	915
MatrigelR matrix	915
MatrigelR matrix	935
the lesion site	976
GFP-labeled cells	993
12 weeks in the lesion cavity	1026
12 weeks	1026
the lesion cavity	1038
the ipsilateral white matter ; the apparent number	1075
the ipsilateral white matter	1075
the apparent number	1105
somal area of fluorogold -LRB- FG -RRB-	1134
somal area	1134
fluorogold -LRB- FG -RRB-	1148
fluorogold	1148
FG	1160
axotomized RST neurons	1172
the NSFC-engrafted rats	1211
lesion controls	1243
Twelve weeks	1260
engraftment	1279
retrograde tracing with FG	1292
retrograde	1292
FG	1316
some RST neurons	1333
axons 4 -- 5 segments caudal	1362
axons 4	1362
5 segments	1370
the engraftment site	1391
dextran amine	1451
regeneration of RST axons	1475
regeneration	1475
RST axons	1491
the transplants	1509
the white matter for 3	1532
the white matter	1532
3	1553
6 segments caudal to the grafts	1555
6 segments	1555
the grafts	1576
A few RST axons	1588
gray matter close	1618
motoneurons	1639
Matrix	1652
regeneration	1680
Behavioral analysis	1694
NSFC-engrafted rats	1728
better performance	1758
spontaneous vertical exploration and horizontal rope walking	1784
spontaneous vertical exploration	1784
horizontal rope walking	1821
lesion MatrigelR	1850
11 weeks post transplantation	1881
11 weeks	1881
These results	1912
the unique potential	1936
human olfactory neuroepithelial-derived progenitors	1960
an autologous source of stem cells for spinal cord repair	2015
an autologous source	2015
stem cells for spinal cord repair	2039
stem cells	2039
spinal cord repair	2054
Introduction The limited regeneration of the adult CNS	2075
Introduction The limited regeneration	2075
Introduction	2075
The limited regeneration	2088
the adult CNS	2116
a variety	2153
factors including glial scaring -LRB- Geller and Fawcett , 2002 -RRB-	2166
factors	2166
glial scaring	2184
glial	2184
Geller and Fawcett	2199
2002	2219
inhibitory factors -LRB- Fawcett , 1997 ; Niederost et al. , 1999 -RRB-	2226
inhibitory factors	2226
Fawcett , 1997 ; Niederost et al. , 1999	2246
Fawcett	2246
1997 ; Niederost et al.	2255
1997	2255
Niederost et al.	2261
Niederost	2261
et al.	2271
1999	2279
lack of trophic support -LRB- Beattie et al. , 1997 -RRB-	2290
lack	2290
trophic support	2298
Beattie	2315
et al. , 1997	2323
et al.	2323
1997	2331
Strategies for spinal cord repair	2338
Strategies	2338
spinal cord repair	2353
exogenous growth factors	2386
Bregman	2412
et al. , 1997 ; Coumans et al. , 2001 ; Kim et al. , 1999 ; Selzer , 2003	2420
et al. , 1997	2420
et al.	2420
1997	2428
Coumans et al. , 2001	2434
Coumans	2434
et al. , 2001	2442
et al.	2442
2001	2450
Kim et al. , 1999	2456
Kim	2456
et al. , 1999	2460
et al.	2460
1999	2468
Selzer , 2003	2474
Selzer	2474
2003	2482
implants of artificial bridges -LRB- Bunge , 2001 ; Teng et al. , 2002 -RRB-	2489
implants	2489
artificial bridges	2501
Bunge , 2001 ; Teng et al. , 2002	2521
Bunge	2521
2001 ; Teng et al.	2528
2001	2528
Teng et al.	2534
Teng	2534
et al.	2539
2002	2547
peripheral nerves -LRB- Carter et al. , 1989 -RRB-	2554
peripheral nerves	2554
Carter	2573
et al. , 1989	2580
et al.	2580
1989	2588
embryonic tissue	2595
Bunge , 2001 ; Murray , 2004 ; Murray and Fischer , 2001	2613
Bunge , 2001	2613
Bunge	2613
2001	2620
Murray , 2004	2626
Murray	2626
2004	2634
Murray and Fischer , 2001	2640
Murray and Fischer	2640
2001	2660
Schwann cells -LRB- Kocsis et al. , 2002 ; Xu et al. , 1995 -RRB-	2667
Schwann cells	2667
Kocsis	2682
et al. , 2002 ; Xu et al. , 1995	2689
et al.	2689
2002 ; Xu et al.	2697
2002	2697
Xu et al.	2703
Xu	2703
et al.	2706
1995	2714
embryonic stem cells	2721
McDonald and Howard	2743
McDonald	2743
Howard	2756
2002 ; McDonald et al. , 1999	2764
2002	2764
McDonald et al. , 1999	2770
McDonald	2770
et al. , 1999	2779
et al.	2779
1999	2787
engineered fibroblasts -LRB- Liu et al. , 1999 , 2002 -RRB-	2798
engineered fibroblasts	2798
Liu	2822
et al. , 1999 , 2002	2826
et al.	2826
1999	2834
2002	2840
the regenerative capacity of the olfactory system	2857
the regenerative capacity	2857
the olfactory system	2886
attention	2921
Olfactory ensheathing cells -LRB- OECs -RRB- from adult olfactory bulbs	2932
Olfactory ensheathing cells -LRB- OECs -RRB-	2932
Olfactory ensheathing cells	2932
OECs	2961
adult olfactory bulbs	2972
limited axonal regeneration	3020
Li et al. , 1998 ; Ruitenberg et al. , 2003 ; Ramer et al. , 2004	3049
Li	3049
et al. , 1998 ; Ruitenberg et al. , 2003 ; Ramer et al. , 2004	3052
et al. , 1998	3052
et al.	3052
1998	3060
Ruitenberg et al. , 2003	3066
Ruitenberg	3066
et al. , 2003	3077
et al.	3077
2003	3085
Ramer et al. , 2004	3091
Ramer	3091
et al. , 2004	3097
et al.	3097
2004	3105
repair	3115
regions	3135
the CNS	3146
Franklin and Barnett	3155
Franklin	3155
Barnett	3168
2000 ; Nieto-Sampedro , 2003 ; Santos-Benito and Ramon - Cueto , 2003	3177
2000	3177
Nieto-Sampedro , 2003 ; Santos-Benito and Ramon - Cueto , 2003	3183
Nieto-Sampedro , 2003	3183
Nieto-Sampedro	3183
2003	3199
Santos-Benito and Ramon	3205
Santos-Benito	3205
Ramon	3223
Cueto , 2003	3230
Cueto	3230
2003	3237
the harvest of OECs from the olfactory bulb	3253
the harvest	3253
OECs from the olfactory bulb	3268
OECs	3268
the olfactory bulb	3278
highly invasive surgery	3306
this a problematic source	3338
clinical therapy -LRB- Barnett et al. , 2000 ; Lu et al. , 2002 -RRB-	3368
clinical therapy	3368
Barnett	3386
et al. , 2000 ; Lu et al. , 2002	3394
et al.	3394
2000 ; Lu et al.	3402
2000	3402
Lu et al.	3408
Lu	3408
et al.	3411
2002	3419
The olfactory neuroepithelium -LRB- ONe -RRB-	3426
The olfactory neuroepithelium	3426
ONe	3457
lifelong repair	3472
progenitors	3491
neuronal and supporting cells -LRB- Calof and Chikaraishi , 1989 -RRB-	3540
neuronal	3540
supporting cells -LRB- Calof and Chikaraishi , 1989 -RRB-	3553
supporting cells	3553
Calof and Chikaraishi , 1989	3571
Calof	3571
Chikaraishi , 1989	3581
Chikaraishi	3581
1989	3594
our lab	3613
the procedures	3631
isolation and culture	3650
human ONe-derived neurosphere-forming cells -LRB- NSFCs -RRB-	3675
human ONe-derived neurosphere-forming cells	3675
NSFCs	3720
cadavers and patients	3732
nasal sinus surgery	3765
characteristics	3825
progenitors -LRB- Roisen et al. , 2001 ; Winstead et al. , 2005 -RRB-	3844
progenitors	3844
Roisen	3857
et al. , 2001 ; Winstead et al. , 2005	3864
et al.	3864
2001 ; Winstead et al.	3872
2001	3872
Winstead et al.	3877
Winstead	3877
et al.	3886
2005	3894
The location of ONe	3901
The location	3901
ONe	3917
it	3927
harvest cells	3942
damage	3972
the donor	3982
our pilot studies	4006
the NSFC lines	4040
brain-derived neurotrophic factor -LRB- BDNF -RRB-	4078
brain-derived neurotrophic factor	4078
BDNF	4113
passage number , donor age , or sex -LRB- Marshall et al. , 2003 -RRB-	4136
passage number	4136
donor age	4152
sex	4166
Marshall	4171
et al. , 2003	4180
et al.	4180
2003	4188
ELISA and RT-PCR studies -LRB- Marshall et al. , 2004 -RRB-	4213
ELISA and RT-PCR studies	4213
Marshall	4239
et al. , 2004	4248
et al.	4248
2004	4256
the therapeutic potential of NSFCs	4275
the therapeutic potential	4275
NSFCs	4304
the red nucleus -LRB- RN -RRB-	4311
the red nucleus	4311
RN	4328
rubrospinal tract -LRB- RST -RRB-	4336
rubrospinal tract	4336
RST	4355
the adult rat , which respond to exogenous BDNF -LRB- Kwon et al. , 2002 -RRB-	4363
the adult rat	4363
exogenous BDNF -LRB- Kwon et al. , 2002 -RRB-	4395
exogenous BDNF	4395
Kwon	4411
et al. , 2002	4416
et al.	4416
2002	4424
an ideal in vivo model	4446
an ideal	4446
model	4463
Infusion	4470
exogenous BDNF	4482
Houle	4498
Ye , 1999 ; Kobayashi et al. , 1997 ; Namiki et al. , 2000 ; Novikova et al.	4508
Ye , 1999	4508
Ye	4508
1999	4512
Kobayashi et al. , 1997	4518
Kobayashi	4518
et al. , 1997	4528
et al.	4528
1997	4536
Namiki et al. , 2000	4542
Namiki	4542
et al. , 2000	4549
et al.	4549
2000	4557
Novikova et al.	4563
Novikova	4563
et al.	4572
2000	4580
transplants of BDNF-engineered fibroblasts/OECs	4589
transplants	4589
BDNF-engineered fibroblasts/OECs	4604
Liu	4638
et al. , 1999 , 2002 ; Ruitenberg et al. , 2003 ; Tobias et al. , 2003	4642
et al.	4642
1999 , 2002 ; Ruitenberg et al. , 2003 ; Tobias et al.	4650
1999 , 2002	4650
1999	4650
2002	4656
Ruitenberg et al. , 2003	4662
Ruitenberg	4662
et al. , 2003	4673
et al.	4673
2003	4681
Tobias et al.	4687
Tobias	4687
et al.	4694
2003	4702
atrophy	4718
RN neurons	4729
regenerative axonal growth	4752
rubrospinal axons in the RST	4782
rubrospinal axons	4782
the RST	4803
The current study aimed to determine if engrafted human adult NSFCs	4812
The current study	4812
human adult NSFCs	4862
rescue axotomized adult rat RN neurons from retrograde atrophy	4923
rescue	4923
adult rat RN neurons	4941
retrograde atrophy	4967
RST axonal regeneration	4998
cervical spinal cord dorsolateral/lateral funiculotomy	5032
Our long-term goal	5088
procedures	5121
a victim of spinal cord injury or other neurological degenerative conditions	5146
a victim	5146
spinal cord injury or other neurological degenerative conditions	5158
spinal cord injury	5158
other neurological degenerative conditions	5180
the donor of progenitors for his/her	5238
the donor	5238
progenitors for his/her	5251
progenitors	5251
his/her	5267
own restorative grafts	5275
the need for immunosuppression or ethical controversy	5306
the need	5306
immunosuppression or ethical controversy	5319
Materials and methods	5362
Materials	5362
methods	5376
Transduction	5384
NSFCs with LERS-EGFP vector	5400
NSFCs	5400
LERS-EGFP vector	5411
Our lab	5428
the culture procedure	5449
ONe-derived NSFC lines	5488
postmortem	5516
patients undergoing nasal sinus surgery	5543
patients	5543
nasal sinus surgery	5563
Roisen et al. , 2001 ; Winstead et al. , 2005 , respectively	5584
Roisen et al.	5584
Roisen	5584
et al.	5591
2001 ; Winstead et al.	5599
2001	5599
Winstead et al.	5605
Winstead	5605
et al.	5614
2005 , respectively	5622
2005	5622
Both ELISA and RT-PCR studies	5643
15 evaluated NSFC lines	5689
15	5689
NSFC lines	5702
BDNF	5721
passage number , donor age , or sex -LRB- Marshall et al. , 2004 -RRB-	5742
passage number	5742
donor age	5758
sex	5772
Marshall	5777
et al. , 2004	5786
et al.	5786
2004	5794
the present experiments	5805
two of these well-characterized NSFC lines	5830
two	5830
these well-characterized NSFC lines	5837
green fluorescent protein -LRB- GFP -RRB-	5917
green fluorescent protein	5917
GFP	5944
the LERS-EGFP vector -LRB- Kinsella and Nolan , 1996 -RRB-	5955
the LERS-EGFP vector	5955
Kinsella and Nolan , 1996	5977
Kinsella	5977
Nolan , 1996	5990
Nolan	5990
1996	5997
transfection	6010
the GFP-labeled cells	6024
7 DIV	6066
medium	6075
90 % Minimal Essential Medium -LRB- MEM -RRB-	6101
90 % Minimal Essential Medium	6101
MEM	6131
Hanks ' salts	6141
Hanks '	6141
lglutamine	6159
10 % fetal bovine serum -LRB- FBS -RRB-	6171
10 % fetal bovine serum	6171
FBS	6195
10 mg % gentamycin	6205
378C	6240
an atmosphere of humidified 5 % CO2 in air	6248
an atmosphere	6248
humidified 5 % CO2 in air	6265
humidified 5 % CO2	6265
air	6286
These two GFP-labeled NSFC lines	6291
up to 40 passages	6342
a feeding schedule of every other day	6365
a feeding schedule	6365
every other day	6387
alternate feedings	6419
Representative passages	6439
liquid nitrogen for future use	6478
liquid nitrogen	6478
future use	6498
Preparation of NSFCs for engraftment One week	6510
Preparation	6510
NSFCs for engraftment One week	6525
NSFCs	6525
engraftment	6535
One week	6547
transplantation , GFP-labeled NSFCs	6565
MEM + 10 % FBS	6636
MEM	6636
10 % FBS	6642
FBS 10 % , 5 % to 2.5 % every 2 DIV , then maintained in MEM + 2.5 % FBS	6667
FBS	6667
10 % , 5 % to 2.5 % every 2 DIV ,	6671
10 %	6671
5 % to 2.5 % every 2 DIV	6676
5 % to 2.5 %	6676
every 2 DIV	6687
MEM + 2.5 % FBS	6719
MEM	6719
2.5 % FBS	6725
Fifteen to thirty minutes prior to injection , NSFCs	6735
Fifteen	6735
thirty minutes	6746
injection , NSFCs	6770
injection	6770
NSFCs	6781
low-speed centrifugation -LRB- 900 rpm for 5 min -RRB-	6814
low-speed centrifugation	6814
900 rpm for 5 min	6840
900 rpm	6840
5 min	6852
MEM	6885
2.5 % FBS	6891
MatrigelR matrix -LRB- 1:1 ; BD Biosciences -RRB- at a concentration of 2	6904
MatrigelR matrix -LRB- 1:1 ; BD Biosciences -RRB-	6904
MatrigelR matrix	6904
1:1 ; BD Biosciences	6922
1:1	6922
BD Biosciences	6927
a concentration of 2	6946
a concentration	6946
2	6965
10 ∧ 4/µl	6969
48C	7000
The remaining cells	7005
3	7056
4 days for in vitro immunocytochemical characterization	7058
4 days	7058
immunocytochemical characterization	7078
BDNF RT-PCR	7119
ELISA analysis	7136
BDNF RT-PCR and ELISA analysis The RNA	7152
BDNF RT-PCR and ELISA analysis	7152
The RNA	7183
NSFCs	7209
the two	7220
GFP-labeled NSFC-lines	7237
RNA Stat-60 reagent -LRB- Tel-Test , Inc -RRB-	7267
RNA Stat-60 reagent	7267
Tel-Test	7288
Inc	7298
The GeneAmp RNA PCR Kit -LRB- Applied Biosystems , N808-0017 -RRB-	7304
The GeneAmp RNA PCR Kit	7304
Applied Biosystems	7329
N808-0017	7349
BDNF RNA	7379
The BDNF primers	7389
the basis	7422
published sequence -LRB- 298 bp -RRB- -LRB- Yamamoto et al. , 1996 -RRB-	7435
published sequence -LRB- 298 bp -RRB-	7435
published sequence	7435
298 bp	7455
Yamamoto	7464
et al. , 1996	7473
et al.	7473
1996	7481
Integrated DNA Technologies , Coralville , IA	7510
Integrated DNA Technologies	7510
Coralville , IA	7539
indicated	7558
5V : 5V-AGCCTCCTCTGCTCTTTCTGCTGGA - 3V ; 3V : 5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7569
5V	7569
5V-AGCCTCCTCTGCTCTTTCTGCTGGA - 3V ; 3V : 5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7573
5V-AGCCTCCTCTGCTCTTTCTGCTGGA - 3V	7573
5V-AGCCTCCTCTGCTCTTTCTGCTGGA	7573
3V	7603
3V : 5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7607
3V	7607
5V-CTTTTGTCTATGCCCCQ TGCAGCCTT-3V	7611
The PCR procedures	7647
protocol	7696
the kit	7709
positive -LRB- pAW109 RNA -RRB-	7728
positive	7728
pAW109 RNA	7738
negative controls -LRB- Eppendorf Mastercycler Gradient -RRB-	7754
negative controls	7754
Eppendorf Mastercycler Gradient	7773
The procedure	7807
an initial step	7834
958C , 2 m	7854
958C	7854
2 m	7860
35 cycles	7866
melt -LRB- 958C , 1 m -RRB-	7879
melt	7879
958C , 1 m	7885
958C	7885
1 m	7891
annealextend -LRB- 608C , 1 m -RRB- and the final step -LRB- 728C , 7 m -RRB-	7897
annealextend -LRB- 608C , 1 m -RRB-	7897
annealextend	7897
608C , 1 m	7911
608C	7911
1 m	7917
the final step -LRB- 728C , 7 m -RRB-	7926
the final step	7926
728C , 7 m	7942
728C	7942
7 m	7948
Separation	7954
2 % agarose gel , stained with 0.05 % ethidium bromide	7988
2 % agarose gel	7988
0.05 % ethidium bromide	8017
Band intensities	8041
Alpha Innotech TMM-20 Transilluminator	8076
BDNF protein levels	8129
these two GFPlabeled NSFCs	8152
these two	8152
NSFCs	8173
ELISA analysis of cell lysates for BDNF	8180
ELISA analysis	8180
cell lysates for BDNF	8198
cell lysates	8198
BDNF	8215
Emax ImmunoAssay system , part #TB257 , Promega , Madison , WI	8221
Emax ImmunoAssay system	8221
part #TB257	8246
Promega	8259
Madison	8268
WI	8277
Cells	8296
lysis buffer -LRB- 1 x 10 ∧ 6 cells/100 µl lysis buffer -RRB- for 10 min on ice	8329
lysis buffer -LRB- 1 x 10 ∧ 6 cells/100 µl lysis buffer -RRB-	8329
lysis buffer	8329
1 x 10 ∧ 6 cells/100 µl lysis buffer	8343
1 x 10 ∧ 6 cells/100	8343
1	8343
10 ∧ 6 cells/100	8347
10 ∧	8347
6 cells/100	8350
µl lysis buffer	8362
10 min on ice	8383
10 min	8383
ice	8393
Acid treatment	8398
the protein	8441
the protein content	8458
a Bio-Rad protein assay -LRB- Bio-Rad laboratories , Hercules , CA -RRB-	8497
a Bio-Rad protein assay	8497
Bio-Rad laboratories	8522
Hercules	8544
CA	8554
Samples containing the same amounts of protein	8559
Samples	8559
the same amounts of protein	8578
the same amounts	8578
protein	8598
the procedures	8626
the BDNF ELISA following the manufacturer 's protocol	8645
the BDNF ELISA	8645
the manufacturer 's protocol	8670
the manufacturer 's	8670
Tertiary antibodies	8699
horseradish peroxidase	8738
Wells	8762
tetramethylbenzidine	8788
450 nm on a standard microplate reader	8825
450 nm	8825
a standard microplate reader	8835
BDNF content	8865
a standard curve calibrated with known amounts of protein	8901
a standard curve	8901
known amounts of protein	8934
known amounts	8934
protein	8951
The detection limit	8960
less than 2.9 pg/ml for BDNF	8984
less than 2.9 pg/ml	8984
BDNF	9008
Experimental design Ninety-four female Sprague -- Dawley rats	9014
Experimental design	9014
Ninety-four female Sprague -- Dawley rats	9034
Dawley	9061
220	9074
270 g ; Charles River , Wilmington , MA	9078
270 g	9078
Charles River , Wilmington , MA	9085
a control group -LRB- n = 12 -RRB-	9134
a control group	9134
n	9151
12	9155
3 experimental groups -LRB- n = 82 -RRB- -LRB- Table 1 -RRB-	9163
3 experimental groups -LRB- n = 82 -RRB-	9163
3 experimental groups	9163
n	9186
82	9190
Table 1	9195
Body weight of experimental animals	9205
Body weight	9205
experimental animals	9220
the experiment as a general measure of health	9262
the experiment	9262
a general measure of health	9280
a general measure	9280
health	9301
The control animals	9309
baseline information	9352
the size and number of cells	9384
the size and number	9384
cells	9407
both the left and right RNs	9420
anterograde	9463
the RN	9509
Table 1	9517
All rats in the experimental groups	9527
All rats	9527
the experimental groups	9539
a dorsolateral/lateral funiculotomy	9572
the right side of the mid-cervical spinal cord	9611
the right side	9611
the mid-cervical spinal cord	9629
a transplant	9669
GFP-labeled NSFCs	9685
MatrigelR matrix or MatrigelR matrix alone 1 week	9716
MatrigelR matrix or MatrigelR matrix	9716
1 week	9759
the lesion	9772
Rats in experimental group I -LRB- n = 12 -RRB-	9793
Rats	9793
experimental group I -LRB- n = 12 -RRB-	9801
experimental group I	9801
n	9823
12	9827
1 or 2 weeks	9847
the survival and migration	9888
the transplanted NSFCs in the injured spinal cord -LRB- Table 1 -RRB-	9918
the transplanted NSFCs	9918
the injured spinal cord -LRB- Table 1 -RRB-	9944
the injured spinal cord	9944
Table 1	9969
Rats in experimental group II -LRB- n = 40 -RRB-	9979
Rats	9979
experimental group II -LRB- n = 40 -RRB-	9987
experimental group II	9987
n	10010
40	10014
the effects	10040
engrafted NSFCs	10055
the axotomized RN neurons and functional recovery -LRB- Table 1 -RRB-	10074
the axotomized RN neurons	10074
functional recovery -LRB- Table 1 -RRB-	10104
functional recovery	10104
Table 1	10125
The RNs of these animals	10135
The RNs	10135
these animals	10146
FG injection	10179
the cervical spinal cord partial hemisection	10198
2 weeks -LRB- IIA , n = 16 -RRB-	10270
IIA , n = 16	10279
IIA	10279
n = 16	10284
n	10284
16	10288
12 weeks -LRB- IIB , n = 24 -RRB-	10295
IIB , n = 24	10305
IIB	10305
n = 24	10310
n	10310
24	10314
post transplantation for RN	10318
post transplantation	10318
RN	10343
histological and image analysis	10346
addition	10382
animals in group IIB	10392
animals	10392
group IIB	10403
the effect	10435
NSFCs	10459
functional recovery	10468
spontaneous vertical exploration and horizontal ropewalking tests	10491
Rats in experimental group III -LRB- n = 30 -RRB-	10558
Rats	10558
experimental group III -LRB- n = 30 -RRB-	10566
experimental group III	10566
n	10590
30	10594
the potential	10620
axotomized RST axonal regeneration -LRB- Table 1 -RRB-	10664
axotomized RST axonal regeneration	10664
Table 1	10700
The RST of some animals -LRB- IIIA , n = 18 -RRB-	10710
The RST	10710
some animals -LRB- IIIA , n = 18 -RRB-	10721
some animals	10721
IIIA , n = 18	10735
IIIA	10735
n = 18	10741
n	10741
18	10745
anterograde transport	10764
dextran amine -LRB- BDA -RRB- 12 weeks post transplantation	10802
dextran amine -LRB- BDA -RRB-	10802
dextran amine	10802
BDA	10817
12 weeks	10822
The animals	10853
an additional 2 weeks	10901
Other animals -LRB- IIIB , n = 12 -RRB-	10924
Other animals	10924
IIIB , n = 12	10939
IIIB	10939
n = 12	10945
n	10945
12	10949
an injection of FG	10964
an injection	10964
FG	10980
the right side of the spinal cord at T1	10988
the right side	10988
the spinal cord at T1	11006
the spinal cord	11006
T1	11025
2 level	11028
3 days	11062
All procedures	11070
the University of Louisville Institutional Animal Care and Use Committee	11102
the University	11102
Louisville Institutional Animal Care and Use Committee	11120
accord	11187
the National Institutes of Health guidelines	11199
Health	11226
the care and use of laboratory animals	11248
the care and use	11248
laboratory animals	11268
Prevention	11288
inflammation with penicillin and immunosuppression with cyclosporine	11302
inflammation	11302
penicillin and immunosuppression with cyclosporine	11320
penicillin and immunosuppression	11320
cyclosporine	11358
all experimental rats	11375
NSFCs engrafted and lesion MatrigelR matrix only	11398
NSFCs engrafted	11398
NSFCs	11398
lesion MatrigelR matrix only	11418
lesion MatrigelR matrix	11418
daily Penicillin G	11449
subcutaneous , 100,000 units/kg ; G.C. Hanford Mfg. , NY	11469
subcutaneous	11469
100,000 units/kg ; G.C. Hanford Mfg.	11483
100,000 units/kg	11483
G.C. Hanford Mfg.	11501
NY	11520
cyclosporine	11528
intramuscular , 10 mg/kg ; Ben Venue Labs , OH	11542
intramuscular	11542
10 mg/kg ; Ben Venue Labs	11557
10 mg/kg	11557
Ben Venue Labs	11567
OH	11583
the day of spinal cord injury	11621
the day	11621
spinal cord injury	11632
1 week after transplantation	11654
1 week	11654
transplantation	11667
Cyclosporine -LRB- 10 mg/kg -RRB-	11684
Cyclosporine	11684
10 mg/kg	11698
6 weeks post transplantation	11742
6 weeks	11742
the dose	11784
5 mg/kg	11808
the remainder	11833
the experimental period -LRB- Liu et al. , 1999 ; Ruitenberg et al. , 2003 -RRB-	11850
the experimental period	11850
Liu	11875
et al. , 1999 ; Ruitenberg et al. , 2003	11879
et al.	11879
1999 ; Ruitenberg et al.	11887
1999	11887
Ruitenberg et al.	11893
Ruitenberg	11893
et al.	11904
2003	11912
the end of the 12-week experimental period	11922
the end	11922
the 12-week experimental period	11933
all animals	11966
body weights of 450 -- 500 g	11982
body weights of 450	11982
body weights	11982
450	11998
500 g	12002
the cyclosporine treatment	12025
not impact	12056
the animals ' health	12081
the animals '	12081
Surgical procedures	12102
Unilateral C3	12122
4 cervical spinal cord dorsolateral/lateral funiculotomy model	12136
the RST	12210
Liu et al. , 1999	12258
Liu	12258
et al.	12262
1999	12270
rats	12286
an intraperitoneal injection	12319
ketamine	12351
100 mg/kg body weight ; Ben Venue Labs , OH	12361
100 mg/kg body weight	12361
Ben Venue Labs , OH	12384
Ben Venue Labs	12384
OH	12400
xylazine	12408
10 mg/kg ; Butler , OH	12418
10 mg/kg	12418
Butler , OH	12428
Butler	12428
OH	12436
The spinal cord	12441
dorsal laminectomy of the C3 and C4 vertebrae	12472
dorsal laminectomy	12472
the C3 and C4 vertebrae	12494
a cavity 1 -- 2 mm in length	12523
cavity 1	12525
2 mm in length	12534
2 mm	12534
length	12542
microscissors and gentle aspiration	12565
microscissors	12565
gentle aspiration	12583
the lateral funiculus on the right side of the cervical spinal cord	12604
the lateral funiculus	12604
the right side of the cervical spinal cord	12629
the right side	12629
the cervical spinal cord	12647
The lesion	12673
the axons of the RST in the ipsilateral dorsolateral funiculus	12703
the axons	12703
the RST in the ipsilateral dorsolateral funiculus	12716
the RST	12716
the ipsilateral dorsolateral funiculus	12727
the ipsilateral ventral funiculus and gray matter	12786
the ipsilateral ventral funiculus	12786
gray matter	12824
the dorsal columns	12845
experimental group II	12875
experimental group	12875
II	12894
the cavity	12898
a small piece of Gelfoam	12925
a small piece	12925
Gelfoam	12942
1 Al 2 %	12962
1 Al	12962
FG -LRB- Fluorochrome , Englewood , CO -RRB-	12970
FG	12970
Fluorochrome	12974
Englewood	12988
CO	12999
The dura mater	13004
a piece of deep fascia removed from the subcutaneous tissue of the neck	13036
a piece	13036
deep fascia removed from the subcutaneous tissue of the neck	13047
deep fascia	13047
the subcutaneous tissue of the neck	13072
the subcutaneous tissue	13072
the neck	13099
The muscles	13109
layers	13136
the skin	13149
wound clips	13174
surgery	13193
the animals	13202
a subcutaneous injection of 5 ml	13225
a subcutaneous injection	13225
5 ml	13253
physiological saline to compensate for blood loss	13258
blood loss	13297
heating pads , closely observed until awake ,	13323
heating pads	13323
their home cages	13388
1 week	13412
the animals	13420
the lesion site	13451
The cavity	13480
micro-scissors	13509
cellular debris	13528
aspiration	13559
A piece of gel foam	13571
A piece	13571
gel foam	13582
the cavity	13607
bleeding	13626
5 -- 10 min	13659
5	13659
10 min	13661
The	13669
NSFCs	13684
8 -- 10 µl , 2 x 10 ∧ 4 / µl cells	13691
8 -- 10 µl , 2 x 10 ∧ 4 /	13691
8	13691
10 µl , 2 x 10 ∧ 4	13693
10 µl , 2 x 10 ∧	13693
10 µl	13693
2 x 10 ∧	13700
2	13700
10 ∧	13704
4	13707
µl cells	13710
MEM + 2.5 % FBS and MatrigelR matrix -LRB- 1:1 -RRB-	13733
MEM	13733
2.5 % FBS and MatrigelR matrix -LRB- 1:1 -RRB-	13739
2.5 % FBS	13739
MatrigelR matrix -LRB- 1:1 -RRB-	13752
MatrigelR matrix	13752
1:1	13770
MEM + 2.5 % FBS and MatrigelR matrix	13778
MEM	13778
2.5 % FBS and MatrigelR matrix	13784
2.5 % FBS	13784
MatrigelR matrix	13797
a 25	13835
Al Hamilton syringe attached to a glass pipette -LRB- 50 µm tip diameter -RRB-	13841
Al Hamilton syringe attached to a glass pipette	13841
Al Hamilton syringe	13841
a glass pipette	13873
50 µm tip diameter	13890
The syringe	13911
1	13948
2 min	13950
the MatrigelR to partially solidify	13965
the gel	14011
the lesion site	14044
The wound	14061
the procedures outlined above	14092
the procedures	14092
anterograde tracing	14127
anterograde	14127
2 weeks	14148
termination of the experiment , animals in experimental group IIIA	14163
termination	14163
the experiment , animals in experimental group IIIA	14178
the experiment	14178
animals in experimental group IIIA	14194
animals	14194
experimental group IIIA	14205
a stereotaxic apparatus	14284
A burr hole	14309
the left surface of the skull over the RN with a dental drill	14333
the left surface	14333
the skull over the RN with a dental drill	14353
the skull	14353
the RN with a dental drill	14368
the RN	14368
a dental drill	14380
the	14398
Mori et al. , 1997	14436
Mori	14436
et al.	14441
1997	14449
1 µl	14459
10 % BDA	14467
10,000 molecular weight in double distilled water ; Molecular Probes	14476
10,000 molecular weight	14476
double distilled water ; Molecular Probes	14503
double distilled water	14503
Molecular Probes	14527
Leiden , The Netherlands	14545
Leiden	14545
The Netherlands	14553
2	14595
3 min in five 200 nl pulses	14597
3 min	14597
five 200 nl pulses	14606
a 10 µl Hamilton syringe	14631
The needle	14657
place for an additional 20 min	14680
place	14680
an additional 20 min	14690
2 -- 3 min	14740
2	14740
3 min	14742
retrograde tracing	14753
retrograde	14753
animals in experimental group IIIB	14773
animals	14773
experimental group IIIB	14784
the right side of their spinal cords	14830
the right side	14830
their spinal cords	14848
T1	14882
2 level for pressure-injection of 0.5 µl 2 % FG	14885
pressure-injection of 0.5 µl	14897
pressure-injection	14897
0.5 µl	14919
the right spinal cord and animals	14937
the right spinal cord	14937
animals	14963
3 days later	14987
Behavioral testing	15001
forelimb use	15030
spontaneous vertical exploration	15050
limb use asymmetries	15121
Kozlowski	15143
et al. , 1996	15153
et al.	15153
1996	15161
Liu et al. , 1999	15167
Liu	15167
et al. , 1999	15171
et al.	15171
1999	15179
McDermott et al. , 1995	15185
McDermott	15185
et al. , 1995	15195
et al.	15195
1995	15203
Schallert and Jones , 1993	15209
Schallert and Jones	15209
1993	15230
Schallert and Lindner , 1990	15236
Schallert and Lindner	15236
1990	15259
Horizontal rope walking	15266
a sensitive test	15311
partial spinal cord hemisection models	15332
specific aspects of behavioral deficits such as posture and balance	15381
specific aspects	15381
behavioral deficits such as posture and balance	15401
behavioral deficits	15401
posture and balance	15429
gait	15456
Murray and Fischer , 2001 ; Ruitenberg et al. , 2003 ; Shumsky et al. , 2003	15462
Murray and Fischer	15462
2001 ; Ruitenberg et al. , 2003 ; Shumsky et al.	15482
2001	15482
Ruitenberg et al. , 2003 ; Shumsky et al.	15488
Ruitenberg	15488
et al. , 2003 ; Shumsky et al.	15499
et al. , 2003	15499
et al.	15499
2003	15507
Shumsky et al.	15513
Shumsky	15513
et al.	15521
2003	15529
the animals	15547
surgery and baseline behavior measurements	15579
The animals in experimental group IIB	15637
The animals	15637
experimental group IIB	15652
11 weeks	15687
surgery	15702
the 2 behavioral tests	15716
spontaneous vertical exploration	15740
horizontal rope walking	15778
Two individuals	15803
the scoring of all behavioral performance tests in a double-blind study	15829
the scoring	15829
all behavioral performance tests in a double-blind study	15844
all behavioral performance tests	15844
a double-blind study	15880
spontaneous vertical exploration testing at 11 weeks after transplantation	15906
spontaneous vertical exploration testing	15906
11 weeks after transplantation	15950
11 weeks	15950
transplantation	15965
the rats	15982
a clear glass cylinder -LRB- 20 cm in diameter and 30 cm high -RRB- for 5 min	16006
a clear glass cylinder -LRB- 20 cm in diameter and 30 cm high -RRB-	16006
a clear glass cylinder	16006
20 cm in diameter and 30 cm	16030
20 cm	16030
diameter and 30 cm	16039
diameter	16039
30 cm	16052
5 min	16068
independent use	16089
the left -LRB- non-impaired -RRB- forelimb , right -LRB- impaired -RRB- forelimb	16108
the left -LRB- non-impaired -RRB- forelimb	16108
the left -LRB- non-impaired -RRB-	16108
the left	16108
right -LRB- impaired -RRB-	16142
right	16142
both -LRB- left and right -RRB- forelimbs	16176
the wall of the cylinder	16223
the wall	16223
the cylinder	16235
vertical posturing along the wall	16255
vertical posturing	16255
the wall	16280
Each behavior	16290
terms of percentage forelimb use of the left	16321
terms	16321
percentage forelimb use of the left	16330
percentage forelimb use	16330
the left	16357
the total number of limb usages -LRB- left , right , and both -RRB-	16394
the total number of limb usages -LRB- left , right	16394
the total number	16394
limb usages -LRB- left , right	16414
limb usages	16414
left	16427
both	16444
horizontal rope walking at 11 weeks after engraftment	16455
horizontal rope	16455
11 weeks	16482
engraftment	16497
the animal 's gait	16510
the animal 's	16510
3 untimed separate	16547
a 1.25-m-long rope -LRB- 4 cm diameter -RRB-	16579
a 1.25-m-long rope	16579
4 cm diameter	16599
one platform to another	16619
one platform	16619
another	16635
Rats	16644
their general performance	16665
rope locomotion	16698
a deficit rating scale : -LRB- 0 -RRB- normal rope locomotion	16720
a deficit rating scale	16720
-LRB- 0 -RRB- normal rope locomotion	16744
-LRB- 0 -RRB- normal rope	16744
0	16745
locomotion	16760
normal locomotion with occasional deficits such as inability	16785
normal locomotion	16785
occasional deficits such as inability	16808
occasional deficits	16808
inability	16836
consistent weight-supported limb placement	16858
traverse ; -LRB- 2 -RRB- able to cross the rope	16908
traverse	16908
-LRB- 2 -RRB- able to cross the rope	16918
able	16922
the rope	16936
deficits ; and -LRB- 3 -RRB- great difficulty to cross the rope	16963
deficits	16963
-LRB- 3 -RRB- great difficulty to cross the rope	16977
great difficulty	16981
the rope	17007
frequent	17017
loss of balance	17033
loss	17033
balance	17041
the rope	17064
the animal	17088
the rope	17108
it	17118
only three times	17135
rope traverse	17160
the number of	17175
the number	17175
total steps for each limb	17210
total steps	17210
each limb	17226
the btotal error/stepQ ratio , which was calculated and defined as the following	17262
the btotal error/stepQ ratio	17262
the following	17328
number of slips + 2 -LRB- number of falls -RRB-	17344
number of slips	17344
number	17344
2 -LRB- number of falls -RRB-	17362
2	17362
number of falls	17365
number	17365
total number	17383
steps	17399
Each rat	17406
three times	17428
final scores	17445
the mean of the 6 scores obtained by the two independent observers	17463
the mean	17463
the 6 scores obtained by the two independent observers	17475
the 6 scores	17475
the two independent observers	17500
Tissue preparation Animals	17531
an overdose	17588
ketamine -LRB- 200 mg/kg body weight -RRB-	17603
ketamine	17603
200 mg/kg body weight	17613
xylazine -LRB- 20 mg/kg body weight -RRB-	17640
xylazine	17640
20 mg/kg body weight	17650
the heart	17690
0.01 M PBS	17705
pH 7.4	17717
200 ml	17725
4 % paraformaldehyde in 0.1 M PB , pH 7.4 -LRB- 48C , 500 ml -RRB-	17745
4 % paraformaldehyde	17745
0.1 M PB , pH 7.4 -LRB- 48C , 500 ml -RRB-	17768
0.1 M PB	17768
pH 7.4 -LRB- 48C , 500 ml -RRB-	17777
pH 7.4	17777
48C , 500 ml	17785
48C	17785
500 ml	17790
The midbrain plus cervical and thoracic segments of the spinal cord	17799
The midbrain	17799
cervical and thoracic segments of the spinal cord	17817
cervical and thoracic segments	17817
the spinal cord	17851
the same fixative	17902
48C overnight	17923
cytoprotection at 48C in PB	17949
cytoprotection	17949
48C in PB	17967
48C	17967
PB	17974
30 % sucrose	17988
1	18004
2 days	18006
Spinal cord and brain tissue	18014
Spinal cord	18014
brain tissue	18030
OCT compound -LRB- Fisher Scientific , Pittsburgh , PA -RRB-	18060
OCT compound	18060
Fisher Scientific	18074
Pittsburgh	18093
PA	18105
a cryostat	18121
The spinal cord	18133
either transverse or horizontal sections	18169
transverse	18176
horizontal sections	18190
20 µm	18213
gelatincoated slides	18236
the entire RN	18273
the midbrains	18302
20 µm from caudal to rostral extent	18356
20 µm	18356
caudal to rostral extent	18367
Every third serial section -LRB- 70 -- 80 -RRB-	18393
Every third serial section	18393
70 -- 80	18421
70	18421
80	18424
gelatin-coated slides in sequence	18445
gelatin-coated slides	18445
sequence	18470
The first series of sections	18480
The first series	18480
sections	18500
toluidine blue staining	18522
analysis of total neuronal number and size for both RN magnocellular regions	18550
analysis of total neuronal number	18550
analysis	18550
total neuronal number	18562
size for both RN magnocellular regions	18588
size	18588
both RN magnocellular regions	18597
The other series of sections	18628
The other series	18628
sections	18648
analysis of the number and size of FG-labeled RN neurons	18671
analysis	18671
the number and size of FG-labeled RN neurons	18683
the number and size	18683
FG-labeled RN neurons	18706
Histology	18729
immunocytochemistry Toluidine blue staining and immunocytochemical procedures	18743
our laboratory -LRB- Othman et al. , 2003 -RRB-	18846
our laboratory	18846
Othman	18862
et al. , 2003	18869
et al.	18869
2003	18877
the NSFCs on coverslips	18893
the NSFCs	18893
coverslips	18906
4V	18943
6-diamidino-2-phenylindole dihydrochloride	18947
DAPI , 1:500 ; Molecular Probes , Eugene , OR	18991
DAPI	18991
1:500 ; Molecular Probes , Eugene	18997
1:500	18997
Molecular Probes , Eugene	19004
Molecular Probes	19004
Eugene	19022
OR	19030
the nuclei -LRB- 378C , 30 min -RRB-	19046
the nuclei	19046
378C , 30 min	19058
378C	19058
30 min	19064
staining	19081
extensive washing	19097
extensive	19097
both coverslips and the tissue on slides	19116
both coverslips	19116
the tissue on slides	19136
the tissue	19136
slides	19150
48C	19189
the primary antibodies listed in Table 2	19198
the primary antibodies	19198
Table 2	19231
secondary antibodies Texas Red-conjugate goat anti-mouse IgG	19255
secondary antibodies	19255
Texas Red-conjugate goat	19276
anti-mouse IgG	19301
Texas Red-conjugate goat anti-rabbit IgG	19320
Texas Red-conjugate goat	19320
anti-rabbit IgG	19345
all	19362
1:100	19374
FITC	19381
Cappel	19387
West Chester , PA	19395
West Chester	19395
PA	19409
Texas Red	19413
Molecular Probes	19424
Eugene	19442
OR	19450
Omission of primary or secondary antibodies	19468
Omission	19468
primary or secondary antibodies	19480
the specificity of the reaction	19520
the specificity	19520
the reaction	19539
The BDA staining procedures	19553
protocols	19600
Kelly	19613
et al. -LRB- 2003 -RRB-	19619
et al.	19619
2003	19627
slides with RN and spinal cord sections	19643
slides	19643
RN and spinal cord sections	19655
three times , 10 min each ,	19695
three times	19695
10 min each	19708
10 min	19708
each	19715
0.1 M PB , pH 7.4 ,	19724
0.1 M PB	19724
pH 7.4	19734
10 %	19762
normal goat serum -LRB- NGS -RRB-	19766
normal goat serum	19766
NGS	19785
phosphate-buffered saline PBS , pH 7.4 -LRB- 30 min -RRB-	19793
phosphate-buffered saline PBS	19793
pH 7.4 -LRB- 30 min -RRB-	19824
pH 7.4	19824
30 min	19832
The slides	19841
room temperature in avidin	19880
room temperature	19880
avidin	19900
horseradish peroxidase -LRB- 1:50 ; ABC ; Vector , Burlingame , CA -RRB-	19924
horseradish peroxidase	19924
1:50	19948
ABC ; Vector , Burlingame , CA	19954
ABC	19954
Vector , Burlingame , CA	19959
PBS	19986
1 % NGS and 0.5 % Triton X-100	19996
1 % NGS	19996
0.5 % Triton X-100	20007
three 10 min	20032
PB and a 10 min rinse	20055
PB	20055
a 10 min rinse	20062
0.1 M sodium acetate , pH 6.0	20080
0.1 M sodium acetate	20080
pH 6.0	20102
the sections	20110
Sigma Fast-DAB compounds -LRB- Sigma , St. Louis , MO -RRB- for 5 -- 10 min	20141
Sigma Fast-DAB compounds -LRB- Sigma , St. Louis , MO -RRB- for 5	20141
Sigma Fast-DAB compounds -LRB- Sigma , St. Louis , MO -RRB-	20141
Sigma Fast-DAB compounds	20141
Sigma	20167
St. Louis	20174
MO	20185
5	20193
10 min	20195
PB washes	20213
PB	20213
some sections	20224
toluidine blue counterstained	20243
ETOH	20293
DPX -LRB- Fluka Chemie AG , Buchs , Switzerland -RRB-	20321
DPX	20321
Fluka Chemie AG , Buchs , Switzerland	20326
Fluka Chemie	20326
AG , Buchs , Switzerland	20339
Cell counts and image analysis	20364
Cell counts	20364
image analysis	20380
consistency between animals and groups	20405
consistency	20405
animals and groups	20425
sequential sections	20445
the spinal cord lesion site as well as the brain stem for each animal	20485
the spinal cord lesion site	20485
the brain stem for each animal	20524
the brain stem	20524
each animal	20543
Images of NSFCs in culture , spinal cord , and midbrain	20556
Images	20556
NSFCs in culture , spinal cord , and midbrain	20566
NSFCs	20566
culture , spinal cord , and midbrain	20575
culture	20575
spinal cord	20584
midbrain	20601
the Olympus confocal microscope	20630
the Nikon microscope with Olympus video camera system	20665
the Nikon microscope with Olympus	20665
the Nikon microscope	20665
Olympus	20691
video camera system	20699
Photoshop Adobe software	20740
Cell size	20766
NIH image analysis software	20797
analysis	20830
GFP-labeled NSFC migration into the host spinal cord 2 weeks after engraftment	20842
GFP-labeled NSFC migration	20842
the host spinal cord 2 weeks after engraftment	20874
the host spinal cord	20874
2 weeks	20895
engraftment	20909
serial cross sections -LRB- 20 µm -RRB-	20922
serial cross sections	20922
20 µm	20945
cervical spinal cord containing the lesion site	20955
cervical spinal cord	20955
the lesion site	20987
GFP antibody	21021
The sections containing the caudal and rostral extent of the graft	21035
The sections	21035
the caudal and rostral extent of the graft	21059
the caudal and rostral extent	21059
the graft	21092
Micrographs -LRB- 200x -RRB-	21114
Micrographs	21114
200x	21127
sections	21136
50 µm	21148
100 µm	21155
250 µm	21163
500 µm	21171
1000 µm , 1500 µm , 2000 µm distance from the rostral or caudal host	21183
1000 µm	21183
1500 µm	21192
2000 µm distance from the rostral	21201
2000 µm distance	21201
the rostral	21223
caudal host	21238
graft interface	21250
cell counts	21280
Only those GFP-labeled cells with distinct cytoplasm and nuclei	21293
Only those GFP-labeled cells	21293
distinct cytoplasm and nuclei	21327
analysis of the RN	21375
analysis	21375
the RN	21387
the first toluidine-blue-stained section containing 3 -- 10 neurons	21395
the first toluidine-blue-stained section	21395
3 -- 10 neurons	21447
3	21447
10 neurons	21449
beginning of the caudal pole of the RN	21476
beginning	21476
the caudal pole of the RN	21489
the caudal pole	21489
the RN	21508
Only sections	21516
the magnocellular region of the RN	21535
the magnocellular region	21535
the RN	21563
the spinal cord	21588
this study -LRB- Mori et al. , 1997 ; Kwon et al. , 2002 -RRB-	21622
this study	21622
Mori	21634
et al. , 1997 ; Kwon et al. , 2002	21639
et al.	21639
1997 ; Kwon et al.	21647
1997	21647
Kwon et al.	21653
Kwon	21653
et al.	21658
2002	21666
The number and size of neurons on both sides of RN	21673
The number and size	21673
neurons on both sides of RN	21696
neurons	21696
both sides of RN	21707
both sides	21707
RN	21721
Sections 4 , 7 , 10 , and 13 , 16 , 19 of set I	21743
Sections 4	21743
7 , 10 , and 13 , 16 , 19 of set I	21755
7 , 10 , and 13	21755
16	21770
19 of set I	21774
19	21774
I	21784
the number and size of FG-labeled RN neurons	21787
the number and size	21787
FG-labeled RN neurons	21810
Sections 5 , 8 , 11 , and 14 , 17 , 20 of set II	21849
Sections 5	21849
8 , 11 , and 14	21861
17	21876
20 of set II	21880
20	21880
set II	21886
toluidine blue staining	21898
only those cells	21923
identifiable nuclei , nucleoli , and characteristic neuronal morphology	21945
identifiable nuclei	21945
nucleoli	21966
characteristic neuronal morphology	21980
FG-labeled neuron counts	22033
overestimation of neuronal numbers	22068
overestimation	22068
neuronal numbers	22086
adjacent sections -LRB- section sets II and III -RRB-	22104
adjacent sections	22104
section sets II and III	22123
section sets	22123
II and III	22136
only those cells appearing on 1 section	22166
1 section	22196
Liu et al. , 1999	22220
Liu	22220
et al.	22224
1999	22232
The cross-sectional area of toluidine-blue-stained or FG-labeled RN neurons	22239
The cross-sectional area	22239
toluidine-blue-stained or FG-labeled RN neurons	22267
200x counting box using an NIH image macro program	22334
200x counting box	22334
an NIH image macro program	22358
The maximal cross-sectional area for each neuron	22386
The maximal cross-sectional area	22386
each neuron	22423
A total of 150 -- 200 RN neurons was measured for each RN .	22449
A total of 150	22449
A total	22449
150	22460
200 RN neurons was measured for each RN	22464
200 RN neurons	22464
each RN	22496
Statistical analysis Data	22505
the histological assessments and behavioral tests	22545
the histological assessments	22545
behavioral tests	22578
significant differences	22613
animal groups using either Student 's t test or oneway ANOVA	22645
animal groups	22645
Student 's t test or oneway ANOVA	22672
Student 's t test	22672
Student 's	22672
oneway ANOVA	22692
The Pearson correlation test	22706
there	22767
possible relationships between different outcome parameters	22778
possible relationships	22778
different outcome parameters	22809
P	22887
0.01	22891
All quantitative data	22897
mean ± standard deviation -LRB- SD -RRB-	22937
mean ± standard deviation	22937
SD	22964
The graphs	22969
Microsoft Excel software	23000
Results Table	23027
1 Animal groups Table	23041
1 Animal groups	23041
Table	23058
2 Primary antibodies Table 3 Neuronal counts and mean soma size in RN	23064
2 Primary antibodies	23064
3 Neuronal counts	23092
soma size	23119
RN	23132
toluidine blue	23136
± SD Fig. 1	23158
± SD Fig.	23158
1	23169
NSFCs	23172
green fluorescent protein -LRB- GFP -RRB-	23200
green fluorescent protein	23200
GFP	23227
the LERS-EGFP vector	23238
4 DIV	23266
60 % of the cells	23272
60 %	23272
the cells	23279
The level of fluorescence of individual cells	23307
The level	23307
fluorescence of individual cells	23320
fluorescence	23320
individual cells	23336
the length of time	23371
the length	23371
time	23385
the previous division -LRB- DIC , confocal optics -RRB-	23395
the previous division	23395
DIC , confocal optics	23418
DIC	23418
confocal optics	23423
Fig. 2 .	23442
Fig.	23442
2	23447
transplantation	23456
the remaining GFP-labeled NSFCs	23473
3 -- 4 DIV	23533
3	23533
4 DIV	23535
BDNF	23583
A	23590
The majority of the cells with nuclei	23593
The majority	23593
the cells with nuclei	23609
the cells	23609
nuclei	23624
4V	23652
6-diamidino-2-phenylindole dihydrochloride	23656
the neuronal marker , h-tubulin III	23723
the neuronal marker	23723
h-tubulin III	23744
-LRB- B -RRB- A few cells	23759
-LRB- B -RRB-	23759
A few cells	23763
A2B5	23799
Trk pan immunoreactivity	23809
some GFP	23852
positive and negative cells	23861
Trk B immunoreactivity	23894
some cellular surfaces	23933
an intensely stained region -LRB- arrow -RRB-	23983
an intensely stained region	23983
arrow	24012
-LRB- E -RRB- A few NSFCs	24020
-LRB- E -RRB-	24020
A few NSFCs	24024
Trk A positive	24041
Trk A	24041
-LRB- F -RRB- Most of the NSFCs	24057
-LRB- F -RRB- Most	24057
-LRB- F -RRB-	24057
Most	24061
the NSFCs	24069
BDNF -LRB- DIC -RRB- , confocal optics	24103
BDNF -LRB- DIC -RRB-	24103
BDNF	24103
DIC	24109
confocal optics	24115
Fig. 3 .	24133
Fig.	24133
3	24138
RT-PCR and ELISA analysis	24141
both of the NSFC lines used in these studies	24181
both	24181
the NSFC lines used in these studies	24189
the NSFC lines	24189
these studies	24212
BDNF mRNA and protein	24236
-LRB- A -RRB- RT-PCR for BDNF	24273
-LRB- A -RRB-	24273
BDNF	24288
a clear PCR product of 298 bp in the cDNA samples	24303
a clear PCR product	24303
298 bp in the cDNA samples	24326
298 bp	24326
the cDNA samples	24336
each of the two GFP-labeled NSFC lines	24358
each	24358
the two GFP-labeled NSFC lines	24366
PCR for BDNF in the absence of reverse transcriptase -LRB- control -RRB-	24398
PCR	24398
BDNF in the absence of reverse transcriptase -LRB- control -RRB-	24406
BDNF	24406
the absence of reverse transcriptase -LRB- control -RRB-	24414
the absence	24414
reverse transcriptase -LRB- control -RRB-	24429
reverse transcriptase	24429
control	24452
no reaction product	24469
the BDNF amplification product	24506
contaminating or genomic DNA	24556
contaminating	24556
genomic DNA	24573
-LRB- B -RRB- ELISA of cell lysates	24586
-LRB- B -RRB-	24586
cell lysates	24599
BDNF protein	24635
each of the two NSFC lines	24664
each	24664
the two NSFC lines	24672
Fig. 4 .	24693
Fig.	24693
4	24698
Photomicrographs	24701
horizontal sections from an engrafted rat cervical spinal cord	24721
horizontal sections	24721
an engrafted rat cervical spinal cord	24746
an engrafted rat	24746
cervical spinal cord	24763
NSFCs within the lesion cavity	24791
NSFCs	24791
the lesion cavity	24804
the host spinal cord -LRB- A -- C -RRB- 1 week	24826
the host spinal cord	24826
A -- C	24848
A	24848
C	24850
1 week	24853
D -- G	24864
D	24864
G	24866
2 weeks	24869
engraftment	24883
The orientation of all sections	24896
The orientation	24896
all sections	24915
left-caudal and right-rostral	24932
left-caudal	24932
right-rostral	24948
-LRB- A -RRB-	24963
A	24964
the large number	24972
GFP-labeled NSFCs -LRB- green -RRB- in the lesion cavity	24992
GFP-labeled NSFCs -LRB- green -RRB-	24992
GFP-labeled NSFCs	24992
the lesion cavity	25021
a few cells within the host spinal cord bridging the injury site	25050
a few cells	25050
the host spinal cord bridging the injury site	25069
the host spinal cord	25069
the injury site	25099
Several GFP-labeled cells	25116
the adjacent host spinal cord -LRB- arrows -RRB-	25161
the adjacent host spinal cord	25161
arrows	25192
B and C	25202
B	25202
C	25208
Higher-magnification images of area	25211
Higher-magnification images	25211
area	25242
in A	25256
the host	25270
graft	25279
interface -LRB- dashed line -RRB-	25285
interface	25285
line	25303
B	25310
A modest GFAPpositive astrocytic presence	25314
few astrocytes being detected in the graft -LRB- C -RRB-	25375
few astrocytes	25375
the graft -LRB- C -RRB-	25408
the graft	25408
C	25419
-LRB- D and E -RRB-	25423
D	25424
E	25430
Low and high power	25433
rostral cervical spinal cord horizontal sections	25455
the level	25507
the dorsolateral columns	25520
numerous GFP-labeled cells	25553
the white matter for up to 2.0 mm	25605
the white matter	25605
up to 2.0 mm	25626
A few of these cells	25640
A few	25640
these cells	25649
long processes that extended into the surrounding tissue -LRB- box in D -RRB-	25665
long processes	25665
the surrounding tissue -LRB- box in D -RRB-	25699
the surrounding tissue	25699
box in D	25723
box	25723
D	25730
-LRB- F -RRB- Most of the GFP-labeled cells	25734
-LRB- F -RRB- Most	25734
-LRB- F -RRB-	25734
Most	25738
the GFP-labeled cells	25746
Trk B receptors	25786
G	25804
The majority of the GFP	25807
The majority	25807
the GFP	25823
cells	25839
h-tubulin III	25850
Fig. 5 .	25875
Fig.	25875
5	25880
Photomicrographs of cervical spinal cord cross sections	25883
Photomicrographs	25883
cervical spinal cord cross sections	25903
the lesion and GFP-labeled NSFCs	25947
the lesion	25947
GFP-labeled NSFCs	25962
the lesion site 2 weeks	25983
the lesion site	25983
2 weeks	25999
transplantation	26013
A -- H	26031
A	26031
H	26033
Caudal	26036
sections from a single rat at 750-Am intervals	26061
sections	26061
a single rat at 750-Am intervals	26075
a single rat	26075
750-Am intervals	26091
the extent of the lesion and the distribution of engrafted NSFCs	26144
the extent	26144
the lesion and the distribution of engrafted NSFCs	26158
the lesion	26158
the distribution of engrafted NSFCs	26173
the distribution	26173
engrafted NSFCs	26193
I -- N	26211
I	26211
N	26213
High-magnification images of corresponding	26216
High-magnification images	26216
corresponding	26245
areas in A -- D and F -- H. -LRB- A and B -RRB-	26268
areas	26268
A -- D and F -- H. -LRB- A and B -RRB-	26277
A -- D and F -- H.	26277
D and F	26279
D	26279
F	26285
A and B	26291
A	26291
B	26297
NSFCs	26300
up to 1.5 mm from the interface of the lesion cavity	26326
up to 1.5 mm	26326
the interface of the lesion cavity	26344
the interface	26344
the lesion cavity	26361
the host spinal cord white matter	26386
the host spinal cord	26386
white matter	26407
Some cells	26421
the corticospinal tract -LRB- cst -RRB- -LRB- I -RRB-	26440
the corticospinal tract -LRB- cst -RRB-	26440
the corticospinal tract	26440
cst	26465
I	26471
most cells	26484
the dorsolateral funiculus -LRB- dlf -RRB- -LRB- J -RRB-	26509
the dorsolateral funiculus -LRB- dlf -RRB-	26509
the dorsolateral funiculus	26509
dlf	26537
J	26543
a few cells	26551
the ventrolateral funiculus	26566
vlf	26595
the ventral columns	26603
vc	26624
-LRB- C -RRB- The caudal host	26629
-LRB- C -RRB-	26629
The caudal host	26633
graft interface	26649
numerous blood vessels	26675
the transplant site -LRB- arrows in K -RRB-	26719
the transplant site	26719
arrows in K	26740
arrows	26740
K	26750
-LRB- D and E -RRB- The epicenter of lesion cavity	26754
-LRB- D and E -RRB- The epicenter	26754
-LRB- D and E -RRB-	26754
D	26755
E	26761
The epicenter	26764
lesion cavity	26781
many engrafted NSFCs	26805
many	26805
NSFCs	26820
The lesion -LRB- dashed line -RRB-	26827
The lesion	26827
line	26846
the dlf -LRB- containing the rubrospinal tract -RRB- , the lateral funiculus	26873
the dlf -LRB- containing the rubrospinal tract -RRB-	26873
the dlf	26873
the rubrospinal tract	26893
the lateral funiculus	26917
lf	26940
the vlf and the gray matter -LRB- GM -RRB-	26968
the vlf and the gray matter	26968
the vlf	26968
the gray matter	26980
-LRB- F -RRB- Cells	27002
the rostral interface of lesion cavity	27031
the rostral interface	27031
lesion cavity	27056
G and H -RRB- NSFCs	27072
the white matter up to 2.0 mm from the lesion cavity	27114
the white matter	27114
to 2.0 mm	27134
the lesion cavity	27149
They	27168
the dlf and lf -LRB- L -RRB-	27195
the dlf and lf	27195
L	27211
some in the fasciculus gracilis -LRB- fg -RRB-	27215
some	27215
the fasciculus gracilis	27223
fg	27248
fasciculus cuneatus -LRB- fc -RRB-	27253
fasciculus cuneatus	27253
fc	27274
cst -LRB- N -RRB-	27283
cst	27283
N	27288
a few	27296
the vlf and vc -LRB- M -RRB-	27305
the vlf and vc	27305
M	27321
The scale bar in H	27325
The scale bar	27325
H	27342
A -- G	27355
G	27357
The scale bar in N	27360
The scale bar	27360
N	27377
I , K -- M. Fig. 6	27390
I	27390
K -- M. Fig. 6	27393
K	27393
M. Fig. 6	27395
M. Fig.	27395
6	27404
The number of the GFP-labeled NSFCs	27407
The number	27407
the GFP-labeled NSFCs	27421
the white matter of the host spinal cord	27452
the white matter	27452
the host spinal cord	27472
2 weeks	27493
engraftment	27507
n	27520
= 6 ; Mean ± SD	27522
= 6	27522
Mean ± SD	27527
The GFPlabeled cells	27539
20 µm cross sections	27579
cervical spinal cords	27617
distances approximately 50 µm	27642
distances	27642
approximately 50 µm	27652
100 µm , 250 µm , 500 µm , and 1000 µm	27673
100 µm	27673
250 µm	27681
500 µm	27689
1000 µm	27701
1500 µm	27710
2000 µm from the rostral	27719
2000 µm	27719
the rostral	27732
the lesion cavity	27766
More GFP-labeled cells -LRB- P < 0.05 -RRB-	27785
More GFP-labeled cells	27785
P < 0.05	27809
P	27809
< 0.05	27811
<	27811
0.05	27813
the rostral than the caudal white matter	27827
the rostral	27827
the caudal white matter	27844
Fig. 7 .	27870
Fig.	27870
7	27875
Histological analysis of the injury sites	27878
Histological analysis	27878
the injury sites	27903
12 weeks	27920
A and B , toluidine blue	27947
A and B	27947
toluidine blue	27956
the lesion only animals	27976
the lesion	27976
only animals	27987
the sites	28001
many cells -LRB- arrows -RRB- but no axons	28028
many cells -LRB- arrows -RRB-	28028
many cells	28028
arrows	28040
no axons	28052
C and D	28063
C	28063
D	28069
However , within the lesion site of	28072
However , within the lesion site	28072
the lesion	28088
animals	28117
transplanted cells that extended processes -LRB- arrows -RRB-	28126
transplanted cells	28126
processes -LRB- arrows -RRB-	28159
processes	28159
arrows	28170
the site	28203
addition	28216
a large population of axons	28226
a large population	28226
axons	28248
the rostral end of the lesion site -LRB- arrowheads -RRB-	28274
the rostral end	28274
the lesion site -LRB- arrowheads -RRB-	28293
the lesion site	28293
arrowheads	28310
E -- H	28324
E	28324
H	28326
the center of the lesion cavity	28332
the center	28332
the lesion cavity	28346
many engrafted cells -LRB- arrows -RRB-	28365
many	28365
cells -LRB- arrows -RRB-	28380
cells	28380
arrows	28387
GAP-43 and MAP-2	28419
arrows in E and F , and G and H , respectively	28437
arrows in E and F , and G and H	28437
arrows in E and F	28437
arrows	28437
E and F	28447
G and H	28460
axons from the host 's spinal cord	28484
axons	28484
the host 's spinal cord	28495
the host 's	28495
GAP-43 or MAP-2 positive -LRB- arrowheads in E and G and H , respectively -RRB-	28528
GAP-43 or MAP-2	28528
arrowheads in E and G and H , respectively	28554
arrowheads in E and G and H	28554
arrowheads	28554
E and G and H	28568
Fig. 8 .	28599
Fig.	28599
8	28604
Photomicrographs of midbrain toluidine blue	28607
Photomicrographs	28607
midbrain toluidine blue	28627
cross sections	28657
the RNs	28680
2 weeks -LRB- A and B -RRB- and 12 weeks -LRB- C and D -RRB-	28688
2 weeks -LRB- A and B -RRB-	28688
A and B	28697
A	28697
B	28703
12 weeks -LRB- C and D -RRB-	28710
C and D	28720
C	28720
D	28726
cervical spinal cord injury and NSFCs engraftment	28735
All sections	28786
approximately 380 µm	28804
the caudal pole of the RN	28830
the caudal pole	28830
the RN	28849
-LRB- A -RRB- Note in the left RN , modest atrophy and apparent neuronal loss	28857
-LRB- A -RRB-	28857
the left RN , modest atrophy and apparent neuronal loss	28869
the left RN	28869
modest atrophy	28882
apparent neuronal loss	28901
2 weeks after hemisection in the lesion only group	28924
2 weeks after hemisection in the lesion	28924
2 weeks	28924
hemisection in the lesion	28938
hemisection	28938
the lesion	28953
only group	28964
-LRB- B -RRB- Partial preservation	28976
B	28977
the size of the left RN neurons as well as apparent numbers of neurons	29004
the size of the left RN neurons	29004
the size	29004
the left RN neurons	29016
apparent numbers of neurons	29047
apparent numbers	29047
neurons	29067
NSFCs engraftment	29095
-LRB- C -RRB-	29114
C	29115
2 weeks	29130
apparent neuronal loss and atrophy of the left RN	29139
apparent neuronal loss	29139
atrophy of the left RN	29166
atrophy	29166
the left RN	29177
12 weeks in the lesion	29217
12 weeks	29217
the lesion	29229
group	29245
contrast	29259
the lesion plus engrafted NSFCs group	29269
the lesion	29269
NSFCs group	29295
a survival of approximately 80 % of the left RN neurons	29311
a survival	29311
approximately 80 % of the left RN neurons	29325
approximately 80 %	29325
the left RN neurons	29346
less atrophy	29380
12 weeks	29396
Fig. 9 .	29407
Fig.	29407
9	29412
Histogram	29415
the relative number -LRB- A -RRB-	29435
the relative number	29435
A	29456
soma size	29468
B	29479
FG-labeled RN neurons between lesion only	29485
FG-labeled RN neurons	29485
lesion only	29515
lesion plus NSFCs engrafted animals 2 and 12 weeks after surgery	29531
lesion plus NSFCs	29531
animals	29559
2 and 12 weeks	29567
surgery	29588
-LRB- A -RRB- More -LRB- * P < 0.001 -RRB- RN neurons were labeled in the	29597
-LRB- A -RRB- More -LRB- * P < 0.001 -RRB-	29597
-LRB- A -RRB- More	29597
-LRB- A -RRB-	29597
More	29601
P <	29608
P	29608
<	29610
0.001	29612
RN neurons	29619
the	29646
animals -LRB- 2 weeks : 360 ± 39 ; 12 weeks : 300 ± 35 -RRB-	29660
animals	29660
2 weeks : 360 ± 39 ; 12 weeks : 300 ± 35	29669
2 weeks	29669
360 ± 39 ; 12 weeks : 300 ± 35	29678
360 ± 39	29678
360	29678
39	29684
12 weeks	29688
12	29688
weeks	29691
300 ± 35	29698
300	29698
35	29704
those in the lesion	29713
those	29713
the lesion	29722
animals -LRB- 2 weeks : 270 ± 25 ; 12 weeks : 200 ± 25 -RRB-	29738
animals	29738
2 weeks : 270 ± 25 ; 12 weeks : 200 ± 25	29747
2 weeks	29747
270 ± 25 ; 12 weeks : 200 ± 25	29756
270 ± 25	29756
270	29756
25	29762
12 weeks	29766
12	29766
weeks	29769
200 ± 25	29776
200	29776
25	29782
-LRB- B -RRB- The mean soma size of surviving RN neurons was	29787
-LRB- B -RRB-	29787
The mean soma size of surviving RN neurons	29791
The mean soma size	29791
surviving RN neurons	29813
P < 0.001	29839
P	29839
< 0.001	29841
<	29841
0.001	29843
smaller	29850
the lesion	29861
only animals -LRB- 2 weeks : 390 ± 25 µm2 ; 12 weeks : 300 ± 25 µm2 -RRB-	29872
only animals	29872
2 weeks : 390 ± 25 µm2 ; 12 weeks : 300 ± 25 µm2	29886
2 weeks	29886
390 ± 25 µm2 ; 12 weeks : 300 ± 25 µm2	29895
390 ± 25 µm2	29895
390	29895
25 µm2	29901
12 weeks	29909
12	29909
weeks	29912
300 ± 25 µm2	29919
300	29919
25 µm2	29925
the	29941
animals -LRB- 2 weeks : 470 ± 30 µm2 ; 12 weeks : 405 ± 25 µm2 -RRB-	29955
animals	29955
2 weeks : 470 ± 30 µm2 ; 12 weeks : 405 ± 25 µm2	29964
2 weeks	29964
470 ± 30 µm2 ; 12 weeks : 405 ± 25 µm2	29973
470 ± 30 µm2	29973
470	29973
30 µm2	29979
12 weeks	29987
12	29987
weeks	29990
405 ± 25 µm2	29997
405	29997
25 µm2	30003
Fig. 10 .	30013
Fig.	30013
10	30018
Fluorescence photomicrographs of midbrain cross sections	30022
Fluorescence photomicrographs	30022
midbrain cross sections	30055
FG-labeled RN neuronal soma -LRB- A and B -RRB- 2 weeks	30084
FG-labeled RN neuronal soma -LRB- A and B -RRB-	30084
FG-labeled RN neuronal soma	30084
A and B	30113
A	30113
B	30119
2 weeks	30122
C and D	30135
C	30135
D	30141
12 weeks	30144
surgery	30159
All sections	30168
approximately 400 µm	30186
the caudal pole of the RN	30212
the caudal pole	30212
the RN	30231
A and B	30240
A	30240
B	30246
Two weeks	30249
surgery	30265
the apparent number and mean soma area of FG-labeled RN neurons	30274
the apparent number	30274
mean soma area of FG-labeled RN neurons	30298
soma area	30303
FG-labeled RN neurons	30316
the lesion	30354
group -LRB- B -RRB-	30379
group	30379
B	30386
the lesion only group -LRB- A -RRB-	30397
the lesion only group	30397
the lesion	30397
A	30420
C and D	30425
C	30425
D	30431
Twelve weeks	30434
surgery	30453
the apparent number and soma area of FG-labeled RN neurons	30462
the apparent number and soma area	30462
FG-labeled RN neurons	30499
the lesion only	30547
C	30564
the lesion	30600
group -LRB- D -RRB-	30625
group	30625
D	30632
Fig. 11 .	30637
Fig.	30637
11	30642
Photomicrographs of C2 BDA-immunostained	30646
Photomicrographs	30646
C2 BDA-immunostained	30666
toluidine blue counterstained spinal cord sections	30691
toluidine	30691
blue counterstained spinal cord sections	30701
the distribution of BDAlabeled RST axons rostral	30755
the distribution	30755
BDAlabeled RST axons rostral	30775
the lesion site	30807
The BDA-labeled RST axons	30824
the dorsolateral funiculus -LRB- dlf -RRB-	30863
the dorsolateral funiculus	30863
dlf	30891
both lesion only -LRB- A and B -RRB-	30899
both lesion only	30899
A and B	30917
A	30917
B	30923
animals -LRB- C and D -RRB-	30940
animals	30940
C and D	30949
C	30949
D	30955
14 weeks	30958
injury and engraftment	30973
BDA-labeled axons	30997
the lesion	31030
group	31046
those found in the engrafted animals	31064
those	31064
the engrafted animals	31079
the	31079
animals	31093
Fig. 12 .	31103
Fig.	31103
12	31108
Photomicrographs of cervical spinal cord horizontal sections	31112
Photomicrographs	31112
cervical spinal cord horizontal sections	31132
BDA	31181
RST axons	31205
the lesion region	31218
14 weeks	31236
transplantation	31251
all sections	31272
the lesion cavity	31315
right	31339
lines	31363
graft	31378
host interfaces	31384
A and B -RRB- Numerous normal	31402
A and B -RRB-	31402
A	31402
B	31408
BDA-labeled RST axons	31427
rostrocaudal parallel alignment in the dorsolateral funiculus	31465
rostrocaudal parallel alignment	31465
the dorsolateral funiculus	31500
-LRB- C and D -RRB- BDA-labeled RST axons	31528
-LRB- C and D -RRB- BDA-labeled RST	31528
C and D	31529
C	31529
D	31535
the lesion boundary	31583
the lesion cavity in a lesion	31623
the lesion cavity	31623
a lesion	31644
animal	31658
-LRB- E -RRB- High power of	31666
-LRB- E -RRB- High power	31666
E	31667
area in D	31693
area	31693
D	31701
a few terminations of RST axons ending at the proximal boundary of lesion	31712
a few terminations	31712
RST axons ending at the proximal boundary of lesion	31734
RST axons	31734
the proximal boundary of lesion	31754
the proximal boundary	31754
lesion	31779
-LRB- F -- L -RRB-	31787
F -- L	31788
F	31788
L	31790
axons sprouting in NSFC-engrafted animals	31797
axons	31797
NSFC-engrafted animals	31816
-LRB- F and G -RRB- Numerous RST axons	31840
-LRB- F and G -RRB- Numerous RST	31840
F and G	31841
F	31841
G	31847
the region rostral	31886
the graft , some axons passed through the rostral graft -- host interface	31908
the graft	31908
some axons passed through the rostral graft -- host interface	31919
some axons	31919
the rostral graft -- host interface	31945
the rostral graft	31945
host interface	31963
the graft	31997
-LRB- H -RRB- Some small-caliber RST axons with branches	32008
-LRB- H -RRB-	32008
Some small-caliber RST	32012
axons with branches	32035
axons	32035
branches	32046
the epicenter of the graft	32072
the epicenter	32072
the graft	32089
-LRB- I -RRB-	32100
A considerable number	32104
BDA-labeled axons with sprouts	32129
BDA-labeled axons	32129
sprouts	32152
the caudal board of the graft	32167
the caudal board	32167
the graft	32187
the caudal graft -- host interface	32212
the caudal graft	32212
host interface	32229
-LRB- J -RRB- Some rostrocaudally directional RST axons	32245
-LRB- J -RRB- Some rostrocaudally directional RST	32245
-LRB- J -RRB-	32245
Some rostrocaudally directional RST	32249
axons	32285
the graft	32308
-LRB- K -RRB- High power of the corresponding areas in J	32319
-LRB- K -RRB- High power	32319
K	32320
the corresponding areas in J	32337
the corresponding areas	32337
J	32364
a larger-caliber axon	32374
two branches ending in terminal bouton-likes structures	32401
two branches	32401
terminal bouton-likes structures	32424
-LRB- L -RRB- Some small-caliber and larger-caliber RST axons	32458
-LRB- L -RRB-	32458
Some small-caliber and larger-caliber RST axons	32462
the caudal graft -- host interface -LRB- dashed line -RRB-	32536
the caudal graft	32536
host interface -LRB- dashed line -RRB-	32553
host interface	32553
line	32576
Scale	32583
A , C , ± 1 mm , others	32594
C , ± 1 mm	32597
C	32597
± 1 mm	32600
100 µm	32615
Fig. 13 .	32624
Fig.	32624
13	32629
Toluidine blue counterstained photomicrographs of C6	32633
Toluidine blue counterstained photomicrographs	32633
C6	32683
7 spinal cord sections	32686
BDA-labeled RST axons	32722
two to three segments caudal to the graft 14 weeks	32756
two to three segments	32756
the graft	32788
14 weeks	32798
engraftment	32813
-LRB- A and B -RRB- Cross C6	32826
-LRB- A and B -RRB-	32826
A	32827
B	32833
Cross C6	32836
7 section	32845
a lesion only animal	32860
a lesion	32860
only animal	32869
no BDAlabeled RST axons	32890
the dorsolateral funiculus -LRB- dlf -RRB-	32917
the dorsolateral funiculus	32917
dlf	32945
the lesion site	32959
-LRB- C and D -RRB- Cross C6	32976
-LRB- C and D -RRB-	32976
C	32977
D	32983
Cross C6	32986
7 section	32995
an NSFC-engrafted animal	33010
BDA-labeled regenerating RST axons in the dlf and gray matter	33049
BDA-labeled regenerating RST axons	33049
the dlf and gray matter	33087
the dlf	33087
gray matter	33099
-LRB- E -RRB- A few BDA-labeled axons -LRB- arrows -RRB- in the white matter	33112
-LRB- E -RRB- A few BDA-labeled axons	33112
-LRB- E -RRB-	33112
A few BDA-labeled axons	33116
arrows	33141
the white matter	33152
lamina VII of the gray matter	33186
lamina VII	33186
the gray matter	33200
-LRB- F -RRB-	33217
F	33218
BDAlabeled axons	33233
the gray matter of lamina IX	33253
the gray matter	33253
lamina IX	33272
Arrows	33283
boutonlike structures	33299
motoneuron soma	33328
Fig. 14 .	33346
Fig.	33346
14	33351
Photomicrographs of midbrain showing FG retrograde tracing of RN neurons .	33355
Photomicrographs of midbrain	33355
Photomicrographs	33355
midbrain	33375
FG	33392
RN neurons	33417
All sections	33429
approximately 400 µm	33447
the caudal pole of the RN	33473
the caudal pole	33473
the RN	33492
the normal control animals -LRB- A -RRB-	33512
the normal control animals	33512
A	33540
FG-labeled regenerated neurons	33544
the left -LRB- axotomized -RRB-	33617
the left	33617
RN region of the NSFCs recipients -LRB- C -RRB-	33639
RN region	33639
the NSFCs recipients -LRB- C -RRB-	33652
the NSFCs recipients	33652
C	33674
no FG positive cell bodies	33682
the left RN of lesion	33729
the left RN	33729
lesion	33744
group -LRB- B -RRB-	33756
group	33756
B	33763
Fig. 15 .	33768
Fig.	33768
15	33773
At 11 weeks	33777
post-engraftment , functional recovery	33789
injured limb usage in NSFC-engrafted animals	33830
injured limb usage	33830
NSFC-engrafted animals	33852
A and B -RRB-	33877
A	33877
B	33883
The lesion	33886
animals	33902
the left -LRB- uninjured -RRB-	33920
the left	33920
the wall of cylinder	33961
the wall	33961
cylinder	33973
The right -LRB- injured -RRB- forepaw	33983
right -LRB- injured -RRB-	33987
right	33987
injured	33994
-LRB- arrows -RRB-	34031
C and D -RRB- In contrast , engrafted animals	34042
C and D -RRB-	34042
C	34042
D	34048
contrast , engrafted animals	34054
contrast	34054
animals	34074
both paws	34094
the cylinder with normal posture -LRB- arrows -RRB-	34115
the cylinder	34115
normal posture -LRB- arrows -RRB-	34133
normal posture	34133
arrows	34149
the fingers of right forepaw extended -LRB- C -RRB-	34174
the fingers	34174
right forepaw extended	34189
right forepaw	34189
C	34213
-LRB- E -RRB- Behavioral analysis of forelimb use .	34217
-LRB- E -RRB-	34217
Behavioral analysis of forelimb use	34221
Behavioral analysis	34221
forelimb use	34244
the normal data of forelimb usage prior to surgery	34270
the normal data	34270
forelimb usage prior to surgery	34289
forelimb usage	34289
surgery	34313
the engrafted animals -LRB- n = 12 -RRB-	34322
the	34322
animals	34336
n	34345
12	34349
significant recovery of use of the injured forelimb alone or together	34360
significant recovery	34360
use of the injured forelimb alone or together	34384
use	34384
the injured forelimb alone or together	34391
the injured forelimb	34391
the uninjured forelimb	34435
lesion only animals -LRB- n = 12 -RRB-	34467
lesion only animals	34467
lesion	34467
only animals	34474
n	34488
12	34492
negligible use of the injured limb	34503
negligible use	34503
the injured limb	34521
Fig. 16 .	34546
Fig.	34546
16	34551
11 weeks	34558
horizontal rope walking	34585
animals	34633
lesion	34649
animals	34661
A and B	34671
A	34671
B	34677
The photographs	34680
the inability of lesion only animals to	34708
the inability	34708
lesion only animals to	34725
lesion	34725
animals	34737
the rope-walking test	34756
In A	34779
the animal	34785
poor posture and body position	34800
poor posture	34800
body position	34817
Slips	34832
the lesioned animals -LRB- B -RRB-	34866
the lesioned animals	34866
B	34888
C and D	34893
C	34893
D	34899
The lesion	34902
animals	34928
near-normal posture	34944
limbs	34969
their bodies and uplifted tails	34981
their bodies	34981
uplifted tails	34998
These animals	35014
the ropewalk	35050
-LRB- E -RRB- Similarly	35064
-LRB- E -RRB-	35064
the total error/step ratio	35079
the lesion	35120
group	35136
the lesion plus engrafted group -LRB- * P < 0.001 -RRB-	35154
the lesion	35154
group -LRB- * P < 0.001 -RRB-	35180
group	35180
P <	35188
P	35188
<	35190
0.001	35192
-LRB- F -RRB- The lesion only group -LRB- n = 12 -RRB-	35200
-LRB- F -RRB- The lesion only group	35200
-LRB- F -RRB-	35200
The lesion	35204
only group	35215
n	35227
12	35231
a higher deficit score -LRB- * P < 0.001 -RRB-	35245
a higher deficit score	35245
P <	35270
P	35270
<	35272
0.001	35274
those	35286
the NSFC transplants -LRB- n = 12 -RRB-	35302
the NSFC transplants	35302
n	35324
12	35328
-LRB- G -RRB- Functional performance of horizontal rope-walking test	35333
-LRB- G -RRB- Functional performance	35333
G	35334
horizontal rope-walking test	35363
RN neuronal survival	35408
Scatter graph of calculated total error	35430
Scatter graph	35430
calculated total error	35447
step ratios plotted against accompanying number of FG-labeled neurons	35471
step ratios	35471
accompanying number of FG-labeled neurons	35499
accompanying number	35499
FG-labeled neurons	35522
a negative correlation	35554
those 2 groups of parameters using Pearson 's correlation test	35585
those 2 groups	35585
parameters using Pearson 's correlation test	35603
parameters	35603
Pearson 's correlation test	35620
Pearson 's	35620
Characterization of GFP-labeled NSFCs	35649
Characterization	35649
GFP-labeled NSFCs	35669
The two selected NSFC lines	35696
GFP	35746
the LERS-EGFP vector ; approximately 60 % of viable cells 4 days	35756
the LERS-EGFP vector	35756
approximately 60 % of viable cells 4 days	35778
approximately 60 %	35778
viable cells	35799
4 days	35812
transfection	35825
Fig. 1	35856
The expression rate of GFP in NSFCs	35865
The expression rate	35865
GFP in NSFCs	35888
GFP	35888
NSFCs	35895
only a slight decrease over the initial 10 passages	35935
only a slight decrease	35935
the initial 10 passages	35963
over 40 %	36005
35 additional passages	36020
This heterogeneous population	36044
a variety of lineage specific markers	36097
a variety	36097
lineage specific markers	36110
MEM + 2.5 % FBS	36139
MEM	36139
2.5 % FBS	36145
the majority -LRB- ~ 95 % -RRB- of the GFP-labeled NSFCs	36155
the majority -LRB- ~ 95 % -RRB-	36155
the majority	36155
~ 95 %	36169
~	36169
95 %	36170
the GFP-labeled NSFCs	36178
beta-tubulin III -LRB- Fig. 2A -RRB-	36218
beta-tubulin III	36218
Fig. 2A	36236
~ 5 %	36252
~	36252
A2B5 , an antibody against a ganglioside-enriched	36274
A2B5	36274
an antibody against a ganglioside-enriched	36280
an antibody	36280
a ganglioside-enriched	36300
glial membranes -LRB- Fig. 2B -RRB-	36326
glial membranes	36326
Fig. 2B	36343
No immunoreactivity	36353
GFAP -LRB- glial fibrillary acidic protein -RRB-	36390
GFAP	36390
glial fibrillary acidic protein	36396
Approximately 20 % of the NSFCs	36430
Approximately 20 %	36430
the NSFCs	36451
Trk pan	36485
an antibody that reacts promiscuously with Trk A , B , or C -LRB- Fig. 2C -RRB-	36494
an antibody	36494
Trk A , B , or C -LRB- Fig. 2C -RRB-	36537
Trk A	36537
B	36544
C	36550
Fig. 2C	36553
Additional studies	36563
most -LRB- 65 % -RRB- of that immunoreactivity	36600
most -LRB- 65 % -RRB-	36600
most	36600
65 %	36606
that immunoreactivity	36614
Trk B -LRB- Fig. 2D -RRB- with fewer cells -LRB- 35 % -RRB-	36644
Trk B -LRB- Fig. 2D -RRB-	36644
Trk B	36644
Fig. 2D	36651
fewer cells -LRB- 35 % -RRB-	36665
fewer cells	36665
35 %	36678
Trk A -LRB- Fig. 2E -RRB-	36696
Trk A	36696
Fig. 2E	36703
none reactive for Trk C. Immunoreactivity for BDNF	36716
none	36716
Trk C. Immunoreactivity for BDNF	36734
Trk C. Immunoreactivity	36734
BDNF	36762
the cytoplasm	36791
the surface of approximately 90 % of the NSFCs -LRB- Fig. 2F -RRB-	36812
the surface	36812
approximately 90 % of the NSFCs -LRB- Fig. 2F -RRB-	36827
approximately 90 %	36827
the NSFCs -LRB- Fig. 2F -RRB-	36848
the NSFCs	36848
Fig. 2F	36859
RT-PCR	36882
the expression of mRNA for BDNF	36902
the expression	36902
mRNA for BDNF	36920
mRNA	36920
BDNF	36929
both GFP-labeled NSFC lines used in the present experiments	36937
both GFP-labeled NSFC lines	36937
the present experiments	36973
Specific bands of RNA encoding BDNF -LRB- 298 bp -RRB-	36998
Specific bands	36998
RNA encoding BDNF -LRB- 298 bp -RRB-	37016
RNA encoding BDNF	37016
298 bp	37035
the cDNA samples	37062
the two GFP-labeled NSFC lines -LRB- Fig. 3A -RRB-	37084
the two GFP-labeled NSFC lines	37084
Fig. 3A	37116
Control reactions	37126
the amplification products	37162
the PCR method and reagents used	37209
the PCR method	37209
reagents used	37228
reagents	37228
specific amplified products	37250
a cDNA source	37288
ELISA of cell lysates from each NSFC line	37316
ELISA	37316
cell lysates from each NSFC line	37325
cell lysates	37325
each NSFC line	37343
40 pg BDNF/mg protein	37371
both lines -LRB- Fig. 3B -RRB-	37396
both lines	37396
Fig. 3B	37408
two different lines	37427
our initial studies	37460
no differences	37481
the two different neurosphere-forming lines	37518
equivalent responses	37569
the NSFCs to engraftment	37593
the NSFCs	37593
engraftment	37606
the response of the host tissues to the engraftment	37629
the response	37629
the host tissues to the engraftment	37645
the host tissues	37645
the engraftment	37665
data from only one line	37695
data	37695
only one line	37705
clarity	37737
Survival and integration	37746
GFP-labeled NSFCs after engraftment into injured host	37774
GFP-labeled NSFCs	37774
engraftment into injured host	37798
engraftment	37798
injured host	37815
spinal cord	37828
A cavity 1.5	37840
A cavity	37840
1.5	37849
2.0 mm	37853
the caudal rostral direction	37868
the right side of the C3 -- 4 spinal cord 1 week	37907
the right side of the C3	37907
the right side	37907
the C3	37925
4 spinal cord 1 week	37932
4 spinal cord	37932
1 week	37946
the lesion -LRB- Fig. 4A -RRB-	37959
the lesion	37959
Fig. 4A	37971
The lesion	37981
the right side of the cervical spinal cord	38007
the right side	38007
the cervical spinal cord	38025
the ipsilateral dorsolateral and lateral funiculi	38073
the ipsilateral dorsolateral	38073
lateral funiculi	38106
the ipsilateral dorsal and ventral funiculi plus gray matter	38143
the ipsilateral dorsal and ventral funiculi	38143
gray matter	38192
the dorsal columns	38214
Figs. 5D and E	38241
Figs. 5D	38241
E	38254
One week	38258
engraftment	38273
transplanted GFP-labeled NSFCs	38286
the lesion cavity	38334
the surrounding host tissue	38368
the interface of the injury site -LRB- Fig. 4A -RRB-	38399
the interface	38399
the injury site -LRB- Fig. 4A -RRB-	38416
the injury site	38416
Fig. 4A	38433
A few GFP-labeled cells	38443
the adjacent host spinal cord -LRB- Fig. 4B -RRB-	38481
the adjacent host spinal cord	38481
Fig. 4B	38512
A relatively mild astrocytic response	38522
the graft -- host interface -LRB- Fig. 4C -RRB-	38578
the graft	38578
host interface	38588
Fig. 4C	38604
Two weeks	38614
engraftment	38630
GFP-positive cells	38643
the lesion cavity -LRB- Figs. 5C -- E and K -RRB-	38674
the lesion cavity	38674
Figs. 5C -- E and K	38693
Figs. 5C	38693
E and K	38702
These cells	38712
host blood vessels that were present throughout the transplant site	38742
host blood vessels	38742
the transplant site	38790
addition	38814
many cells	38824
the host	38852
spinal cord	38861
a longitudinal direction -LRB- Figs. 4D and E -RRB-	38886
a longitudinal direction	38886
Figs. 4D and E	38912
Figs. 4D	38912
E	38925
The majority of these cells	38929
The majority	38929
these cells	38945
the white matter of spinal cord	38973
the white matter	38973
spinal cord	38993
the dorsolateral	39019
lateral funiculi -LRB- Figs. 5B and J , G and L -RRB-	39040
lateral funiculi	39040
Figs. 5B and J , G and L	39058
Figs. 5B	39058
J , G and L	39071
some in the dorsal columns -LRB- Figs. 5A and I , H and N -RRB-	39084
some	39084
the dorsal columns	39092
Figs. 5A and I	39112
Figs. 5A	39112
I	39125
H and N	39128
H	39128
N	39134
a few in the ventral columns and ventrolateral funiculus	39142
the ventral columns	39151
Figs. 5G and M	39200
Figs. 5G	39200
M	39213
contrast	39220
only a few of the engrafted cells	39230
only a few	39230
the engrafted cells	39244
the	39244
cells	39258
the gray matter adjacent to the injury site -LRB- Figs. 5B , C , and F -RRB-	39280
the gray matter adjacent to the injury site	39280
the gray matter	39280
the injury site	39308
Figs. 5B , C , and F	39325
Figs. 5B	39325
C	39335
F	39342
The quantitative analyses	39346
the number of engrafted cells in the rostral white matter	39390
the number	39390
cells in the rostral white matter	39414
cells	39414
the rostral white matter	39423
almost 2 times that in the caudal regions of all animals evaluated	39452
almost 2 times	39452
the caudal regions of all animals	39475
the caudal regions	39475
all animals	39497
Fig. 6	39520
The cells	39529
the rostral white matter up to 2 mm	39553
the rostral white matter	39553
2 mm	39584
the lesion	39594
they	39622
a maximum of 1.5 mm -LRB- Fig. 6 -RRB-	39643
a maximum of 1.5 mm	39643
Fig. 6	39664
The majority of GFP-labeled cells	39673
The majority	39673
GFP-labeled cells	39689
the Trk B receptor -LRB- Fig. 4F -RRB-	39725
the Trk B receptor	39725
Fig. 4F	39745
h-tubulin III	39757
some	39776
characteristic neuronal shapes	39795
long processes that extended into the surrounding tissue -LRB- Fig. 4G -RRB-	39831
long processes	39831
the surrounding tissue -LRB- Fig. 4G -RRB-	39865
the surrounding tissue	39865
Fig. 4G	39889
Twelve weeks	39899
transplantation	39918
toluidine blue histological staining	39935
toluidine	39935
blue histological staining	39945
profound differences	39981
the cytoarchitecture of the lesion site between the lesion	40005
the cytoarchitecture	40005
the lesion site between the lesion	40029
the lesion site	40029
the lesion	40053
NSFC animals and the lesion only animals	40079
NSFC animals	40079
the lesion	40096
animals	40112
the lesion only animals	40124
the lesion	40124
only animals	40135
the cavity	40149
many cells but no axons -LRB- Figs. 7A and B -RRB-	40176
many cells	40176
no axons -LRB- Figs. 7A and B -RRB-	40191
no axons	40191
Figs. 7A and B	40201
Figs. 7A	40201
B	40214
the lesion site of the engrafted animals	40234
the lesion site	40234
the engrafted animals	40253
the	40253
animals	40267
NSFCs	40276
processes	40295
the site	40316
Figs. 7C -- H	40326
Figs. 7C	40326
H	40335
a large population of axons	40352
a large population	40352
axons	40374
the proximal end of the lesion site -LRB- Fig. 7C -RRB-	40400
the proximal end	40400
the lesion site -LRB- Fig. 7C -RRB-	40420
the lesion site	40420
Fig. 7C	40437
Immunocytochemistry	40447
many GFP-labeled NSFCs	40485
the lesion cavity -LRB- Figs. 7E and F -RRB-	40524
the lesion cavity	40524
Figs. 7E and F	40543
Figs. 7E	40543
F	40556
These cells	40560
GAP-43	40590
growth-associated-protein 43	40598
MAP2	40631
microtubule-associated-protein	40637
neuronal phenotypes -LRB- Figs. 7C -- H -RRB-	40678
neuronal phenotypes	40678
Figs. 7C -- H	40699
Figs. 7C	40699
H	40708
long processes that extended into the surrounding tissue	40723
long processes	40723
the surrounding tissue	40757
addition to the engrafted NSFCs , numerous GAP-43 or MAP2	40784
addition	40784
the engrafted NSFCs , numerous GAP-43 or MAP2	40796
the	40796
NSFCs , numerous GAP-43 or MAP2	40810
NSFCs	40810
numerous GAP-43	40817
MAP2	40836
positive axons from the host 's spinal cord	40841
positive axons	40841
the host 's spinal cord	40861
the host 's	40861
the center of the cavity of the NSFC-engrafted animals -LRB- Figs. 7E -- H -RRB-	40901
the center	40901
the cavity of the NSFC-engrafted animals -LRB- Figs. 7E -- H -RRB-	40915
the cavity	40915
the NSFC-engrafted animals -LRB- Figs. 7E -- H -RRB-	40929
the NSFC-engrafted animals	40929
Figs. 7E -- H	40957
Figs. 7E	40957
H	40966
No obvious GAP-43 or MAP2 positive axons	40970
No obvious GAP-43	40970
MAP2 positive axons	40991
the cavity of lesion	41032
the cavity	41032
lesion	41046
animals	41058
Effects of axotomy and NSFC engraftment	41067
Effects	41067
axotomy and NSFC engraftment	41078
RN neurons	41110
normal rats	41124
toluidine-blue-stained sections	41137
the number	41192
soma size of RN neurons	41212
soma size	41212
RN neurons	41225
Cell	41237
size and numbers	41242
the right	41262
RN	41281
Table 3	41298
no differences	41321
number	41353
soma size of neurons	41368
soma size	41368
neurons	41381
the right RN	41392
normal , lesion only , or lesion plus NSFCengrafted rats at 2 or 12 weeks	41419
normal	41419
lesion only	41427
lesion plus NSFCengrafted rats at 2 or 12 weeks	41443
lesion	41443
NSFCengrafted rats at 2 or 12 weeks	41455
NSFCengrafted rats	41455
at 2 or 12 weeks	41474
transplantation	41497
P N 0.05	41514
P N	41514
0.05	41518
Table 3 ; Fig. 8	41524
Table 3	41524
Fig. 8	41533
the normal animals	41554
the apparent number and mean soma size of neurons in the left RN	41574
the apparent number	41574
mean soma size of neurons in the left RN	41598
soma size of neurons	41603
soma size	41603
neurons	41616
the left RN	41627
more	41649
the lesion	41657
the cellengrafted group	41681
2 or 12 weeks post transplantation	41708
2 or 12 weeks	41708
the lesion only animals	41747
the lesion	41747
only animals	41758
there	41772
a 27 % reduction in the apparent numbers of neurons in the RN	41782
a 27 % reduction	41782
the apparent numbers of neurons in the RN	41801
the apparent numbers	41801
neurons in the RN	41825
neurons	41825
the RN	41836
a 13 % reduction	41856
the lesion plus NSFC-engrafted animals 2 weeks following engraftment	41875
the lesion	41875
NSFC-engrafted animals 2 weeks following engraftment	41891
NSFC-engrafted animals	41891
2 weeks	41914
engraftment	41932
P < 0.05	41945
P	41945
< 0.05	41947
<	41947
0.05	41949
the mean neuronal size	41969
24 % in the lesion	42005
24 %	42005
the lesion	42012
only animals	42023
a 7 % decrease	42048
the lesion plus engrafted group	42065
the lesion	42065
group	42091
P < 0.05 ; Table 3 ; Figs. 8A and B	42098
P	42098
< 0.05 ; Table 3 ; Figs. 8A and B	42100
< 0.05	42100
<	42100
0.05	42102
Table 3	42108
Table	42108
3	42114
Figs. 8A and B	42117
Figs. 8A	42117
B	42130
12 weeks after engraftment	42137
12 weeks	42137
engraftment	42152
the neuronal atrophy of the left RN	42165
the neuronal atrophy	42165
the left RN	42189
the lesion	42228
group	42244
the lesion plus NSFC-engrafted group -LRB- Table 3 ; Figs. 8C and D -RRB-	42278
the lesion	42278
NSFC-engrafted group -LRB- Table 3 ; Figs. 8C and D -RRB-	42294
NSFC-engrafted group	42294
Table 3 ; Figs. 8C and D	42316
Table 3	42316
Figs. 8C and D	42325
The decreases in apparent neuronal number and size	42342
The decreases	42342
apparent neuronal number and size	42359
38 % and 42 %	42398
the lesion only animals	42428
the lesion	42428
only animals	42439
the lesion plus cell-engrafted animals	42462
the lesion	42462
cell-engrafted animals	42478
both parameters	42502
reductions of 24 % and 20 %	42545
reductions	42545
24 % and 20 %	42559
24 %	42559
20 %	42567
P < 0.05 ; Table 3	42586
P	42586
< 0.05 ; Table 3	42588
< 0.05	42588
<	42588
0.05	42590
Table 3	42596
The number	42606
neurons projecting to the spinal cord after axotomy in the lesion only	42620
neurons	42620
the spinal cord	42642
axotomy in the lesion	42664
axotomy	42664
the lesion	42675
lesion plus cell-engrafted animals	42695
lesion	42695
cell-engrafted animals	42707
sections with the FG labeling	42747
sections	42747
the FG labeling	42761
all groups	42781
the mean size of FG-labeled neurons	42793
the mean size	42793
FG-labeled neurons	42810
approximately 11 %	42833
the mean cell size determined from adjacent sections stained for toluidine blue	42863
the mean cell size	42863
adjacent sections stained for toluidine blue	42898
adjacent sections	42898
toluidine blue	42928
immunoflorescence	42951
visible light -LRB- Table 3 ; Figs. 9 and 10 ; Mori et al. , 1997 -RRB-	42997
visible light	42997
Table 3 ; Figs. 9 and 10 ; Mori et al. , 1997	43012
Table 3	43012
Figs. 9 and 10 ; Mori et al. , 1997	43021
Figs. 9 and 10	43021
Mori et al. , 1997	43037
Mori	43037
et al. , 1997	43042
et al.	43042
1997	43050
The FG labeling	43057
the same pattern	43086
the data obtained from the toluidine-blue-stained sections	43106
the data	43106
the toluidine-blue-stained sections	43129
Two weeks	43166
engraftment	43182
the apparent number and size of FG-labeled RN neurons	43195
the apparent number and size	43195
FG-labeled RN neurons	43227
the lesion	43264
the lesion only animals -LRB- P < 0.001 ; Figs. 9 , 10A and B -RRB-	43302
the lesion only animals	43302
the lesion	43302
P < 0.001 ; Figs. 9 , 10A and B	43327
P	43327
< 0.001 ; Figs. 9 , 10A and B	43329
< 0.001	43329
<	43329
0.001	43331
Figs. 9 , 10A and B	43338
Figs. 9	43338
10A	43347
B	43355
12 weeks	43378
the apparent number and size of FG-labeled axotomized RN neurons	43388
the apparent number and size	43388
FG-labeled axotomized RN neurons	43420
FG-labeled	43420
RN neurons	43442
the lesion	43484
group	43500
the lesion plus engraftment group -LRB- P b 0.001 ; Figs. 9 and 10C and D -RRB-	43538
the lesion	43538
engraftment group -LRB- P b 0.001 ; Figs. 9 and 10C and D -RRB-	43554
engraftment group	43554
P b	43573
0.001 ; Figs. 9 and 10C and D	43577
0.001	43577
Figs. 9 and 10C and D	43584
Figs. 9	43584
10C and D	43596
Potential	43608
NSFCs	43631
axotomized RST axonal regeneration	43648
the NSFC engraftment	43699
axonal regeneration	43729
the surviving axotomized RN neurons	43752
the distribution of RST axons in the spinal cord	43789
the distribution	43789
RST axons in the spinal cord	43809
RST axons	43809
the spinal cord	43822
injection of the anterograde tracer BDA	43844
injection	43844
the anterograde tracer BDA	43857
the magnocellular portion of the RN	43889
the magnocellular portion	43889
the RN	43918
the upper cervical segments -LRB- C1 --	43943
the upper cervical segments	43943
C1	43972
rostral	43979
the lesion site	43990
the distribution of the BDA-positive RST axons in lesion only and engrafted	44007
the distribution	44007
the BDA-positive RST axons	44027
lesion only	44057
animals	44083
normal animals in the superficial dorsolateral white matter contralateral	44106
normal animals	44106
the superficial dorsolateral white matter contralateral	44124
the BDA injection site -LRB- Fig. 11 -RRB-	44183
the BDA injection site	44183
Fig. 11	44207
A few ipsilaterally descending RST axons	44217
A few	44217
RST axons	44248
the same location	44284
The BDA-positive RST axons in the lesion	44303
The BDA-positive RST axons	44303
the lesion	44333
animals	44349
sparser	44366
the	44382
animals	44396
the result of the decreased efficiency of atrophied neurons to take up	44423
the result	44423
the decreased efficiency of atrophied neurons to take up	44437
the decreased efficiency	44437
atrophied neurons	44465
transport tracer in the lesion only animals -LRB- Fig. 11 -RRB-	44498
transport tracer	44498
the lesion only animals -LRB- Fig. 11 -RRB-	44518
the lesion only animals	44518
the lesion	44518
Fig. 11	44543
sagittal sections of lesion site	44556
sagittal sections	44556
lesion site	44577
all BDA-labeled axons	44590
the rostral host -- graft interface in lesion	44623
the rostral host	44623
graft interface in lesion	44640
graft interface	44640
lesion	44659
animals	44671
Figs. 12C -- E	44680
Figs. 12C	44680
E	44690
contrast	44697
animals	44720
axons	44729
the rostral host -- graft interface , elongated caudally , and in most cases	44743
the rostral host	44743
graft interface , elongated caudally , and in most cases	44760
graft interface	44760
most cases	44804
the caudal host -- graft interface -LRB- Figs. 12F -- I -RRB-	44829
the caudal host	44829
graft interface	44846
Figs. 12F -- I	44863
Figs. 12F	44863
I	44873
the normal linear rostrocaudal alignment	44889
the RS tract axons located in the dorsolateral funiculus	44933
the RS tract axons	44933
the dorsolateral funiculus	44963
Figs. 12A and B	44991
Figs. 12A	44991
B	45005
most of the regenerated axons	45009
most	45009
the regenerated axons	45017
a rostral	45095
caudal direction -LRB- Figs. 12G -- I -RRB-	45105
caudal direction	45105
Figs. 12G -- I	45123
Figs. 12G	45123
I	45133
addition	45140
the majority of regenerated axons	45150
the majority	45150
regenerated axons	45166
smallcaliber axons	45189
branches or terminal bouton-like structures -LRB- Figs. 12G -- J and L -RRB-	45213
branches or terminal bouton-like structures	45213
branches	45213
Figs. 12G -- J and L	45258
Figs. 12G	45258
J and L	45268
These structures	45278
normal RS tract axons	45319
the middle level -LRB- C3 -- C4 -RRB- of the cervical spinal cord	45344
the middle level -LRB- C3 -- C4 -RRB-	45344
the middle level	45344
C3 -- C4	45362
C3	45362
C4	45366
the cervical spinal cord	45373
Serial cross sections of segments caudal to the lesion site	45399
Serial cross sections	45399
segments caudal to the lesion site	45424
segments	45424
the lesion site	45443
BDA-labeled axons	45477
all lesion only animals	45499
all lesion	45499
only animals	45510
no BDA-labeled RST axons	45524
the dorsolateral funiculus of the host spinal cord caudal	45566
the dorsolateral funiculus	45566
the host spinal cord caudal	45596
the lesion -LRB- Figs. 13A and B -RRB-	45627
the lesion	45627
Figs. 13A and B	45639
Figs. 13A	45639
B	45653
78 % of the engrafted animals	45660
78 %	45660
the engrafted animals	45667
the	45667
animals	45681
regenerated axons	45690
caudal	45719
the lesion site	45729
some cases	45749
BDA-labeled RST axons	45761
the upper thoracic spinal cord -LRB- T1 --	45796
the upper thoracic spinal cord	45796
T1	45828
four	45835
six segments caudal to the transplant , although their distribution was sparser	45843
six segments	45843
the transplant , although their distribution was sparser	45866
the transplant	45866
their distribution	45891
the upper cervical segments	45934
The BDA-labeled RST axons in C6	45963
The BDA-labeled RST axons	45963
C6	45992
8 spinal cord segments were not as well organized as those in the C1	45995
8 spinal cord segments	45995
those in the C1	46048
those	46048
the C1	46057
2 segments -LRB- Figs. 11C and D , 13C and D -RRB-	46064
2 segments	46064
Figs. 11C and D , 13C and D	46076
Figs. 11C	46076
D , 13C and D	46090
Most	46105
the dorsolateral funiculus	46126
a few	46157
the adjoining dorsal horn -LRB- Figs. 13C and D -RRB-	46189
the adjoining dorsal horn	46189
Figs. 13C and D	46216
Figs. 13C	46216
D	46230
Many collaterals	46234
Rexed 's laminae V	46279
Rexed 's	46279
VII -LRB- Fig. 13E -RRB-	46297
VII	46297
Fig. 13E	46302
bouton-like structures near neurons in these laminae	46317
bouton-like structures	46317
neurons in these laminae	46345
neurons	46345
these laminae	46356
A few BDA-labeled fibers	46371
lamina IX in very close apposition	46413
lamina IX	46413
very close apposition	46426
motoneurons -LRB- Fig. 13F -RRB-	46451
motoneurons	46451
Fig. 13F	46464
These results	46475
axotomized RN neurons	46502
RST axons	46536
segments of spinal cord caudal	46551
segments	46551
spinal cord caudal	46563
the lesion site	46585
their target gray matter	46627
the origin	46674
the BDA-labeled axons found in the spinal cord caudal to the lesion site	46688
the BDA-labeled axons	46688
the spinal cord caudal	46719
the lesion site	46745
NSFCs grafted animals	46762
NSFCs	46762
animals	46776
T1 -- 2 for retrograde tracing of FG in the ipsiltaeral spinal cord	46801
T1	46801
2 for retrograde tracing of FG in the ipsiltaeral spinal cord	46804
2	46804
retrograde tracing of FG in the ipsiltaeral spinal cord	46810
retrograde	46810
FG in the ipsiltaeral spinal cord	46832
FG	46832
the ipsiltaeral spinal cord	46838
This injection site	46867
FG	46911
the lesion site	46931
the contralateral lesioned RN	46955
FG-labeled RST neurons	46986
all six NSFC-engrafted rats -LRB- Fig. 14C -RRB-	47026
all six NSFC-engrafted rats	47026
Fig. 14C	47055
any lesion only animals -LRB- Fig. 14B -RRB-	47077
any lesion only animals	47077
any lesion	47077
Fig. 14B	47102
the normal control -LRB- Fig. 14A -RRB-	47125
the normal control	47125
Fig. 14A	47145
the number of regenerated RST neurons in the RN of cell engrafted rats	47156
the number	47156
regenerated RST neurons in the RN of cell engrafted rats	47170
regenerated RST neurons	47170
the RN of cell engrafted rats	47197
the RN	47197
cell engrafted rats	47207
cell	47207
rats	47222
their cell body size	47242
normal RN neurons	47289
some axtomoized RST neurons	47324
some	47324
RST neurons	47340
at least 4 -- 5 segments caudal to the lesion site	47368
at least 4	47368
5 segments caudal to the lesion site	47379
5 segments	47379
the lesion	47400
The detailed morphology	47417
quantitative data for FG coexistence with GAP-43 in RST neurons	47445
quantitative data	47445
FG coexistence with GAP-43 in RST neurons	47467
FG coexistence	47467
GAP-43 in RST neurons	47487
GAP-43	47487
RST neurons	47497
evaluation	47529
Potential	47541
NSFCs	47564
functional recovery	47581
surgery , the animals used for experimental group IIB	47610
surgery	47610
the animals used for experimental group IIB	47619
the animals	47619
experimental group IIB	47640
the spontaneous vertical exploration and rope-walking tests	47687
functional recovery	47781
transplantation	47807
stable baseline data	47824
Only those animals	47863
almost equal usage	47891
the left and right forepaws -LRB- approximate 10 % respectively , Fig. 15E -RRB-	47913
the left and right forepaws	47913
approximate 10 % respectively , Fig. 15E	47942
approximate 10 % respectively	47942
approximate	47942
Fig. 15E	47972
the wall of the cylinder	47993
the wall	47993
the cylinder	48005
the rope-walking tasks	48031
a 0 deficit score	48059
surgery	48095
Eleven weeks	48104
surgery	48123
spontaneous vertical exploration by the lesion	48132
spontaneous vertical exploration	48132
the lesion	48168
only animals	48179
abnormal posture and rare use of the right forelimb	48212
abnormal posture and rare use	48212
the right forelimb	48245
a glass cylinder -LRB- Figs. 15A and B -RRB-	48280
a glass cylinder	48280
Figs. 15A and B	48298
Figs. 15A	48298
B	48312
the other hand	48319
the lesioned animals that received NSFC transplants freely	48335
the lesioned animals	48335
NSFC transplants	48370
both paws	48399
the cylinder	48420
nearly normal posture -LRB- Figs. 15C and D -RRB-	48445
nearly normal posture	48445
Figs. 15C and D	48468
Figs. 15C	48468
D	48482
pre-surgery scores	48498
bilateral forelimb use	48520
the cylinder wall	48554
approximately 80 %	48573
the lesion only animals	48593
the lesion	48593
only animals	48604
both forelimbs	48622
10 %	48643
the time	48650
only the unaffected forelimb -LRB- left ; approximately 90 % ; Fig. 15E -RRB-	48676
only the unaffected forelimb	48676
left ; approximately 90 % ; Fig. 15E	48706
left	48706
approximately 90 % ; Fig. 15E	48712
approximately 90 %	48712
Fig. 15E	48731
Fig.	48731
15E	48736
contrast	48745
the cell-engrafted group	48755
both forelimbs 75 % of the time	48785
both forelimbs	48785
the time	48807
the normal data	48827
surgery	48852
addition	48864
the ipsilateral -LRB- right -RRB- forelimb	48874
the ipsilateral -LRB- right -RRB-	48874
the ipsilateral	48874
8 %	48921
the time in NSFC-engrafted group	48927
the time	48927
NSFC-engrafted group	48939
functional recovery	48975
the injured limb	48998
the lesion	49042
animals -LRB- Fig. 15E -RRB-	49058
animals	49058
Fig. 15E	49067
the cell-engrafted animals	49089
better performance	49131
the rope-walking test 11 weeks post-engraftment	49157
the rope-walking test	49157
11 weeks	49179
the lesion	49210
group	49226
all operated animals	49236
all	49236
animals	49249
deficits in general locomotion	49258
deficits	49258
general locomotion	49270
a significant difference in deficit scores	49313
a significant difference	49313
deficit scores	49341
the lesion plus NSFC-engrafted	49374
the lesion	49374
NSFC-engrafted	49390
lesion only groups -LRB- P < 0.001 ; Fig. 16F -RRB-	49409
lesion	49409
only groups -LRB- P < 0.001 ; Fig. 16F -RRB-	49416
only groups	49416
P < 0.001 ; Fig. 16F	49429
P	49429
< 0.001 ; Fig. 16F	49431
< 0.001	49431
<	49431
0.001	49433
Fig. 16F	49440
Fig.	49440
16F	49445
Most engrafted animals	49451
Most	49451
animals	49466
consistent locomotor activity , better body posture	49478
consistent locomotor activity	49478
better body posture	49509
the task	49556
They	49566
the rope	49592
lesion	49622
animals	49634
Figs. 16A -- D	49643
Figs. 16A	49643
D	49653
The calculated total error	49657
step ratio	49685
the behavioral data obtained by the deficit-scoring method	49716
the behavioral data	49716
the deficit-scoring method	49748
A significant difference	49776
the two experimental groups -LRB- P < 0.001 ; Fig. 16E -RRB-	49824
the two experimental groups	49824
P < 0.001 ; Fig. 16E	49853
P	49853
< 0.001 ; Fig. 16E	49855
< 0.001	49855
<	49855
0.001	49857
Fig. 16E	49864
Fig.	49864
16E	49869
the surviving axotomized RN	49905
neurons	49933
the observed functional recovery	49956
the possible correlation	49990
the number of FG-labeled RN neurons and the total error/step	50023
the number	50023
FG-labeled RN neurons and the total error/step	50037
FG-labeled RN neurons	50037
the total error/step	50063
Pearson 's correlation test	50103
Pearson 's	50103
A negative correlation	50131
the morphological and physiological data	50170
= n	50214
2 = 14 , r = -0.731 , P < 0.002	50220
2 = 14	50220
2	50220
14	50224
r = -0.731	50228
r	50228
-0.731	50232
P < 0.002	50240
P <	50240
P	50240
0.002	50244
Fig. 16G	50252
Rats that performed well during horizontal rope walking	50263
Rats	50263
horizontal rope walking	50295
many surviving FG-labeled neurons in axotomized RN	50338
many surviving FG-labeled neurons	50338
axotomized RN	50375
animals that slipped or fell from the rope more frequently	50398
animals	50398
the rope	50432
a fewer neurons in axotomized RN	50474
a fewer neurons	50474
RN	50504
Discussion This study	50509
Discussion	50509
This study	50520
human adult olfactory neuroepithelial-derived progenitors -LRB- NSFCs -RRB-	50549
human adult olfactory neuroepithelial-derived progenitors	50549
NSFCs	50608
the injured adult rat cervical spinal cord remain viable	50630
the injured adult rat	50630
cervical spinal cord	50652
They	50688
the injured host spinal cord	50709
RN neurons	50761
retrograde atrophy	50777
RST axonal regeneration	50816
functional recovery either directly or by modification of the microenvironment	50854
functional recovery	50854
directly or by modification of the microenvironment	50881
directly or by modification	50881
the microenvironment	50912
the lesion site	50956
Integration	50973
human ONe-derived NSFCs in injured rat spinal cord The	50998
human ONe-derived NSFCs	50998
injured rat	51025
spinal cord	51037
NSFCs	51063
the injured rat spinal cord	51081
at least 12 weeks	51113
They	51132
the lesion cavity ; some integrated into the adjacent host spinal cord	51153
the lesion cavity	51153
some integrated into the adjacent host spinal cord	51172
some	51172
the adjacent host spinal cord	51193
a relatively continuous interface	51235
the host tissues that was not interrupted by cysts or scars	51274
the host tissues	51274
cysts or scars	51319
Several features of NSFCs and their interaction with the spinal cord likely	51335
Several features	51335
NSFCs and their interaction with the spinal cord likely	51355
NSFCs	51355
their interaction with the spinal cord likely	51365
their interaction	51365
the spinal cord likely	51388
the spinal cord	51388
their survival	51426
In vitro pilot studies	51442
the NSFC lines	51480
BDNF , irrespective of passage number	51518
BDNF	51518
passage number	51540
donor age	51556
sex	51570
ELISA and RT-PCR studies	51593
Marshall	51619
et al. , 2004	51628
et al.	51628
2004	51636
the present study	51646
RTPCR , cell lysate ELISA , and immunocytochemistry	51665
RTPCR	51665
cell lysate ELISA	51672
immunocytochemistry	51695
the two GFP-transfected NSFC lines used in this study	51733
the two GFP-transfected NSFC lines	51733
this study	51776
BDNF	51809
Preliminary studies	51815
the concentration of BDNF	51861
the concentration	51861
BDNF	51882
NSFC-conditioned media	51890
detection levels	51918
Cultures	51945
higher NSFC densities	51964
increased levels of BDNF in the conditioned medium	52002
increased levels	52002
BDNF in the conditioned medium	52022
BDNF	52022
the conditioned medium	52030
The presence	52054
Trk B receptors	52070
some NSFCs coupled with the presence of BDNF in their cell lysates	52089
some NSFCs	52089
the presence of BDNF	52113
the presence	52113
BDNF	52129
their cell lysates	52137
a possible paracrine/autocrine mechanism -LRB- Novikova et al. , 1996 -RRB-	52165
a possible paracrine/autocrine mechanism	52165
Novikova	52207
et al. , 1996	52216
et al.	52216
1996	52224
In vitro studies	52231
patient age , sex , or duration in culture	52268
patient age	52268
sex	52281
duration in culture	52289
duration	52289
culture	52301
the viability or polyamine synthetic activity	52324
the NSFCs -LRB- Marshall et al. , 2003 ; Roisen et al. , 2001 -RRB-	52373
the NSFCs	52373
Marshall	52384
et al. , 2003 ; Roisen et al. , 2001	52393
et al.	52393
2003 ; Roisen et al.	52401
2003	52401
Roisen et al.	52407
Roisen	52407
et al.	52414
2001	52422
The GFPtransfected NSFC lines	52429
their high proliferative activity and GFP expression	52470
many passages	52555
engraftment	52586
the NSFCS	52599
the absence of serum over a period of weeks	52625
the absence	52625
serum over a period of weeks	52640
serum	52640
a period of weeks	52651
a period	52651
weeks	52663
passages	52672
a series of dilutions from 10 % to 0 % serum -LRB- Zhang et al. , 2004 -RRB-	52689
a series	52689
dilutions from 10 % to 0 % serum -LRB- Zhang et al. , 2004 -RRB-	52701
dilutions	52701
10 % to 0 % serum -LRB- Zhang et al. , 2004 -RRB-	52716
10 % to 0 % serum	52716
Zhang	52733
et al. , 2004	52739
et al.	52739
2004	52747
this manner	52757
the engrafted NSFCs	52770
the	52770
NSFCs	52784
BDNF	52804
their survival	52820
the local environment	52846
they	52871
the injured adult rat spinal cord	52892
Fibroblasts genetically engineered to release BDNF	52927
Fibroblasts	52927
BDNF	52973
similar conditions	53000
RST neuronal atrophy	53031
axotomy -LRB- Liu et al. , 1999 -RRB-	53058
axotomy	53058
Liu	53067
et al. , 1999	53071
et al.	53071
1999	53079
the present studies	53097
the engrafted NSFCs	53130
the	53130
NSFCs	53144
trophic factors	53190
BDNF	53216
the axotomized RST neurons from retrograde atrophy and possible cell loss	53234
the	53234
RST neurons	53249
retrograde atrophy and possible cell loss	53266
retrograde atrophy	53266
possible cell loss	53289
Another important feature	53309
the apparent histocompatibility	53339
the engrafted NSFCs and the host spinal cord	53379
the	53379
NSFCs and the host spinal cord	53393
NSFCs	53393
the host spinal cord	53403
Only a mild astrocytic response	53425
the graft	53476
the lesion cavity	53489
The removal	53508
presumed scar issue in the lesion cavity just prior to the engraftment	53523
presumed scar issue	53523
the lesion cavity	53546
the engraftment	53578
a role	53610
the lack of scar formation	53620
the lack	53620
scar formation	53632
The mild host immune reaction	53648
immunosuppression	53696
cyclosporine	53717
The antibiotic and possible anti-inflammatory action of Penicillin	53731
The antibiotic and possible anti-inflammatory action	53731
Penicillin	53787
the NSFCs survival	53827
a preliminary study	53850
transplanted NSFCs in the normal rat spinal cord	53871
transplanted NSFCs	53871
the normal rat spinal cord	53893
the adjacent host tissues -LRB- Roisen et al. , 2002 ; Xiao et al. , 2003 -RRB-	53978
the adjacent host tissues	53978
Roisen	54005
et al. , 2002 ; Xiao et al. , 2003	54012
et al.	54012
2002 ; Xiao et al.	54020
2002	54020
Xiao et al.	54026
Xiao	54026
et al.	54031
2003	54039
the present study	54049
many of the engrafted NSFCs	54068
many	54068
the engrafted NSFCs	54076
the	54076
NSFCs	54090
some distance in the rostral , predominantly , and caudal cord	54110
some distance	54110
the rostral , predominantly , and caudal cord	54127
the rostral	54127
caudal cord	54159
The majority of the NSFCs	54172
The majority	54172
the NSFCs	54188
the white matter among the descending supraspinal or ascending sensory fibers	54214
the white matter	54214
the descending supraspinal or ascending sensory fibers	54237
the descending	54237
sensory fibers	54277
some	54293
the gray matter adjacent to the lesion site	54314
the gray matter	54314
the lesion site	54342
addition	54362
most NSFCs	54372
neuron-like morphologies	54387
h-tubulin III immunopositive processes or Trk B receptors on their surface	54417
h-tubulin III immunopositive processes	54417
h-tubulin	54417
III immunopositive processes	54427
Trk B receptors on their surface	54459
Trk B receptors	54459
their surface	54478
They	54493
spinal cord repair	54517
accessory cells -LRB- Wirth et al. , 2001 -RRB- ,	54564
accessory cells	54564
Wirth	54581
et al. , 2001	54587
et al.	54587
2001	54595
trophic factors such as BDNF	54612
trophic factors	54612
BDNF	54636
Liu	54642
et al. , 1999	54646
et al.	54646
1999	54654
growth-permissive extracellular matrix molecules	54683
regenerating axons	54758
the lesion site -LRB- Geller and Fawcett , 2002 -RRB-	54785
the lesion site	54785
Geller and Fawcett	54802
2002	54822
The numerous GAP-43 and MAP2 positive host axons	54829
the lesion cavity of engrafted animals compared to the lesion	54887
the lesion cavity	54887
animals	54918
the lesion	54938
animals	54954
these possibilities	54983
summary	55007
it	55016
the environment provided by the injured cord	55034
the environment	55034
the injured cord	55062
the survival , migration , and differentiation	55091
the	55139
NSFCs	55153
other models -LRB- McDonald et al. , 1999 -RRB-	55175
other models	55175
McDonald	55189
et al. , 1999	55198
et al.	55198
1999	55206
Effects	55213
ONe-derived NSFCs	55234
the axotomized RN neurons Injury to the RST at C3 -- 4 in this study	55255
the axotomized RN neurons Injury to the RST at C3	55255
the	55255
RN neurons	55270
Injury to the RST at C3	55281
Injury	55281
the RST at C3	55291
the RST	55291
C3	55302
4 in this study	55305
4	55305
this study	55310
an apparent reduction	55333
neuronal numbers -LRB- 27 % -RRB- and somal atrophy -LRB- 24 % -RRB-	55358
neuronal numbers	55358
27 %	55376
somal atrophy	55385
24 %	55400
2 weeks	55405
surgery	55419
more significant changes -LRB- 38 % and 42 % , respectively -RRB-	55433
more significant changes	55433
38 % and 42 % , respectively	55459
38 % and 42 %	55459
38 %	55459
42 %	55467
12 weeks post operation	55486
12 weeks	55486
These results	55511
previous reports of spinal cord injury on RST neurons	55540
previous reports	55540
spinal cord injury on RST neurons	55560
spinal cord injury	55560
RST neurons	55582
Feringa et al. , 1988 ; Houle and Ye , 1999 ; Prendergast and Stelzner , 1976	55595
Feringa	55595
et al. , 1988 ; Houle and Ye , 1999 ; Prendergast and Stelzner , 1976	55603
et al. , 1988	55603
et al.	55603
1988	55611
Houle and Ye , 1999	55617
Houle	55617
Ye , 1999	55627
Ye	55627
1999	55631
Prendergast and Stelzner , 1976	55637
Prendergast and Stelzner	55637
1976	55663
The application	55670
fetal cell transplants	55689
Bregman and Reier , 1986 ; Mori et al. , 1997	55713
Bregman and Reier	55713
1986 ; Mori et al.	55732
1986	55732
Mori et al.	55738
Mori	55738
et al.	55743
1997	55751
neurotrophic factors	55761
Houle and Ye , 1999 ; Jin et al. , 2002 ; Kobayashi et al. , 1997	55783
Houle and Ye	55783
Houle	55783
Ye	55793
1999 ; Jin et al.	55797
1999	55797
Jin et al.	55803
Jin	55803
et al.	55807
2002 ; Kobayashi et al. , 1997	55815
2002	55815
Kobayashi et al. , 1997	55821
Kobayashi	55821
et al. , 1997	55831
et al.	55831
1997	55839
BDNF secreting cells	55855
Liu	55877
et al. , 1999 , 2002	55881
et al.	55881
1999	55889
2002	55895
some axotomized RN cell atrophy	55928
some	55928
RN cell atrophy	55944
this experiment	55964
the engrafted NSFCs	55981
the	55981
NSFCs	55995
some perikaryal atrophy of axotomized RN as well as apparent cell loss	56011
some perikaryal atrophy	56011
RN as well as apparent cell loss	56049
RN	56049
apparent cell loss	56063
Two important elements	56083
rescue of RN neurons	56130
rescue	56130
RN neurons	56140
axotomy-induced retrograde atrophy	56156
One	56192
the engrafted NSFCs	56204
the	56204
NSFCs	56218
a surrogate source of BDNF	56243
a surrogate source	56243
BDNF	56265
the RST axons in proximity of the lesion/graft site	56274
the RST axons	56274
proximity of the lesion/graft site	56291
proximity	56291
the lesion/graft site	56304
The other	56327
the relatively high level of graft survival and graft -- host interface	56345
the relatively high level	56345
graft survival and graft -- host interface	56374
graft survival and graft	56374
host interface	56399
a relatively permissive environment	56423
axonal regeneration and possible synapse formation with target neurons	56475
axonal regeneration and possible synapse formation	56475
target neurons	56531
Many GAP-43 positive processes	56547
this presumption as well as the presence of BDA-labeled RST axons	56586
this presumption	56586
the presence of BDA-labeled RST axons	56614
the presence	56614
BDA-labeled RST axons	56630
the NSFCs within the lesion cavity of engrafted animals	56658
the NSFCs	56658
the lesion cavity of engrafted animals	56675
the lesion cavity	56675
animals	56706
Effects	56715
ONe-derived NSFCs on functional recovery and RST axonal regeneration The results	56736
ONe-derived NSFCs on functional recovery	56736
ONe-derived NSFCs	56736
functional recovery	56757
RST axonal regeneration The results	56781
RST axonal regeneration	56781
The results	56805
NSFC engraftment	56842
functional recovery	56860
Eleven weeks	56890
engraftment	56909
the NSFC-engrafted animals	56922
better locomotor activity	56959
horizontal rope walking	56992
lesion only animals , and significant improvements in forelimb usage ipsilateral	57021
lesion only animals	57021
lesion	57021
only animals	57028
significant improvements in forelimb usage ipsilateral	57046
significant improvements	57046
forelimb usage ipsilateral	57074
the lesion	57104
the wall of a cylinder	57130
the wall	57130
a cylinder	57142
the enhanced functions	57167
the anatomical recovery	57211
RN neurons	57249
animals	57273
higher FG labeling	57291
less atrophy	57314
RN neurons , RST axonal regeneration and innervation	57330
RN neurons	57330
RST axonal regeneration	57342
innervation	57370
target gray matter	57385
This	57405
the enhanced function	57424
repair of the RN and RST pathway	57486
repair	57486
the RN and RST pathway	57496
Further support for this	57520
Further support	57520
this	57540
studies	57556
anterograde BDA-labeled RST axons	57567
RST axons	57630
grafted animals	57643
they	57701
the graft	57721
some instances	57739
their target motoneurons	57760
It	57786
these contacts	57804
the forelimb functional recovery	57834
These results	57868
previous studies -LRB- Kuchler et al. , 2002 ; Teng et al. , 2002 -RRB-	57903
previous studies	57903
Kuchler	57921
et al. , 2002 ; Teng et al. , 2002	57929
et al.	57929
2002 ; Teng et al.	57937
2002	57937
Teng et al.	57943
Teng	57943
et al.	57948
2002	57956
Three possible mechanisms	57963
the recovery	58007
The NSFCs	58025
growth factors that directly supported RN neurons and RST axonal regeneration	58044
growth factors	58044
RN neurons and RST axonal regeneration	58083
RN neurons	58083
RST axonal regeneration	58098
-LRB- 2 -RRB- the transplanted cells modified the microenviron	58123
the	58127
cells modified the microenviron	58144
cells	58144
the microenviron	58159
ment within or surrounding the lesion site to facilitate this recovery	58177
ment	58177
the lesion site	58204
this recovery	58234
some GFP-labeled NSFCs	58262
locations in which descending supraspinal or ascending sensory tracts	58299
locations	58299
sensory tracts	58354
the presence of the NSFCs or the secretion of BDNF from the cells	58370
the presence of the NSFCs	58370
the presence	58370
the NSFCs	58386
the secretion of BDNF from the cells	58399
the secretion	58399
BDNF from the cells	58416
BDNF	58416
the cells	58426
other systems	58454
the corticospinal tract	58476
ventrolateral funiculus	58501
dorsal columns	58526
ventral columns	58546
The presence of MAP2 positive dendrites within the region of the lesion cavity	58563
The presence	58563
MAP2 positive dendrites within the region of the lesion cavity	58579
MAP2 positive dendrites	58579
the region of the lesion cavity	58610
the region	58610
the lesion cavity	58624
an indicator of other systems ' axonal response	58649
an indicator	58649
other systems ' axonal response	58665
other systems '	58665
the presence of the NSFCs	58699
the presence	58699
the NSFCs	58715
This hypothesis	58726
further	58746
the existence of FG-labeled regenerated neurons	58767
the existence	58767
FG-labeled regenerated neurons	58784
some vestibular and reticular nuclei	58818
animals -LRB- experimental group IIIB , data not shown -RRB-	58868
animals	58868
experimental group IIIB , data not shown	58877
experimental group IIIB	58877
data not shown	58902
data	58902
Further analysis by anterograde or retrograde tracing	58919
Further analysis	58919
anterograde or retrograde	58939
transplanted NSFCS	59006
regeneration	59033
motor	59060
sensory axons	59080
spinal cord injury	59100
This possibility , individually or collectively ,	59120
This possibility	59120
the effects on the RST pathway	59173
the effects	59173
the RST pathway	59188
the enhanced functional recovery	59220
Potential mechanisms	59254
RST axonal regeneration in NSFC-engrafted cord	59278
RST axonal regeneration	59278
NSFC-engrafted cord	59305
quantitative evaluation of anterograde-labeled axonal regeneration warrants	59329
quantitative evaluation	59329
anterograde-labeled axonal regeneration warrants	59356
further study	59405
conclusion	59423
these studies	59435
neural progenitors	59466
adult human olfactory epithelium following engraftment into host spinal cord	59499
adult human olfactory epithelium	59499
engraftment into host spinal cord	59542
engraftment	59542
host spinal cord	59559
axotomized RN neurons	59589
RST axonal regeneration	59620
enhanced function	59657
Work with olfactory bulbderived ensheathing cells	59676
Work	59676
olfactory bulbderived ensheathing cells	59686
similar effects	59736
spinal cord repair and axonal regeneration and repair	59755
spinal cord repair	59755
axonal regeneration and repair	59778
Franklin and Barnett , 2000 ; Li et al. , 1998 ; Lu et al. , 2002	59810
Franklin and Barnett	59810
2000 ; Li et al. , 1998 ; Lu et al.	59832
2000	59832
Li et al. , 1998 ; Lu et al.	59838
Li	59838
et al. , 1998 ; Lu et al.	59841
et al. , 1998	59841
et al.	59841
1998	59849
Lu et al.	59855
Lu	59855
et al.	59858
2002	59866
the highly invasive surgery that is required to obtain these cells	59882
the highly invasive surgery	59882
these cells	59937
their practical use	59957
contrast	59981
NSFCs harvested from ONe	59991
NSFCs	59991
ONe	60012
an adult neural progenitor source	60024
minimal invasive surgery	60085
a unique therapeutic potential	60123
use	60158
autologous grafting/transplantation strategies	60165
spinal cord injuries and other neurodegenerative disorders	60231
spinal cord injuries	60231
other neurodegenerative disorders	60256
